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Abstract 
Roger M. Arce 
Periodontal disease and Preterm Delivery: Influences of Campylobacter rectus 
Infection on Placental Innate Immunity 
(Under the direction of Dr. Steven Offenbacher) 
Preterm delivery (PTD) is the major cause of neonatal mortality/ morbidity in the 
world. PTD pathogenesis can be initiated by multiple mechanisms; however 
inflammation is the most crucial step that leads to membrane weakening, placental 
rupture and early uterine contraction initiation. Maternal infections are believed to 
account for most of preterm delivery cases (25-40%), and uterine infections have been 
reported to be the leading cause of PTD. Vaginal microorganisms are capable of reaching 
the fetal membranes and inducing local proinflammatory response (chorioamnionitis) that 
ultimately results in PTD. Nonetheless, the treatment of symptomatic and/or 
asymptomatic uterine infections during pregnancy has revealed contradictory results in 
decreasing PTD rates. It has been speculated that other pathogens may come from 
different untreated focal infections in the body that reach the uterus through 
hematogenous dissemination and infect the maternal-fetal interface. In particular, 
Campylobacter rectus is a Gram negative anaerobe harbored in periodontitis-associated 
oral biofilms that has shown the competence to translocate to the fetoplacental unit and 
operate as a potential fetal infectious agent eliciting prematurity. Moreover, a number of 
clinical studies have found an association between periodontitis and preterm delivery. 
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Maternal periodontitis has been found to be associated with increased risk for fetal 
exposure to periodontal pathogens in PTD cases. Yet, the underlying biological 
mechanisms sustaining preterm delivery onset after C. rectus infection remain largely 
unknown. This dissertation hypothesized that C rectus induces a placental innate 
inflammatory response mediated by Toll-like receptors (TLRs). Our experimental data on 
animal models have demonstrated C. rectus ability to disseminate from distant sites of 
infection, to induce a local placental inflammatory response along with a fetal 
intrauterine growth restriction phenotype, and to upregulate TLR-4 expression in 
placental trophoblasts after infection. The experimental results here presented 
demonstrated the importance of TLRs in mediating proinflammatory phenotype both in 
vitro (human trophoblastic cell line) and in vivo (murine) infection models in response to 
C. rectus infection. Taken together, the results here presented will elucidate in part the 
maternal/fetal biological mechanisms leading to PTD in humans, bringing new insights, 
theories and health policies into the preterm delivery field.  
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Abbreviations/Glossary 
 
Abortion, Septic; Any type of abortion, induced or spontaneous, that is associated with 
infection of the uterus and its appendages. It is characterized by fever, uterine tenderness, 
and foul discharge. 
Aggregatibacter actinomycetemcomitans: A species of gram-negative, facultative 
anaerobic spherical or rod-shaped bacteria that associates with species of actynomices in 
actinomycotic lesions and mainly found in severe infections in the oral cavity, mainly the 
periodontium. 
Acute-Phase Proteins: Proteins that are secreted into the blood in increased or decreased 
quantities by hepatocytes in response to trauma, inflammation, or disease. These proteins 
can serve as inhibitors or mediators of the inflammatory processes. Certain acute-phase 
proteins have been used to diagnose and follow the course of diseases or as tumor 
markers. 
Alveolar Bone Loss: Resorption or wasting of the tooth-supporting bone (alveolar 
process) in the maxilla or mandible. 
Amniotic Fluid: A clear, yellowish liquid that envelopes the fetus inside the sac of 
amnion. In the first trimester, it is likely a transudate of maternal or fetal plasma. In the 
second trimester, amniotic fluid derives primarily from fetal lung and kidney. Cells or 
substances in this fluid can be removed for prenatal diagnostic tests (Amniocentesis). 
Anaerobiosis: The complete absence, or (loosely) the paucity, of gaseous or dissolved 
elemental oxygen in a given place or environment. 
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Analysis of Variance (ANOVA): A statistical technique that isolates and assesses the 
contributions of categorical independent variables to variation in the mean of a 
continuous dependent variable. 
Antagonists & inhibitors: Used with chemicals, drugs, and endogenous substances to 
indicate substances or agents which counteract their biological effects by any mechanism. 
Antibodies: Immunoglobulin molecules having a specific amino acid sequence by virtue 
of which they interact only with the antigen (or a very similar shape) that induced their 
synthesis in cells of the lymphoid series (especially plasma cells). 
Bacterial adhesiveness (adhesins): Cell-surface components or appendages of bacteria 
that facilitate adhesion to other cells or to inanimate surfaces. Most fimbriae of gram-
negative bacteria function as adhesins. 
Birth Weight: The mass or quantity of heaviness of an individual at BIRTH. It is 
expressed by units of pounds or kilograms. 
Blastocyst: A post-morula pre-implantation mammalian embryo that develops from a 32-
cell stage into a fluid-filled hollow ball of over a hundred cells. A blastocyst has two 
distinctive tissues. The outer layer of trophoblasts gives rise to extra-embryonic tissues. 
The inner cell mass gives rise to the embryonic disc and eventual embryo proper. 
Campylobacter fetus (C. fetus): A species of bacteria present in man and many kinds of 
animals and birds, often causing infertility and/or abortion. 
Campylobacter jejuni (C. jejuni): A species of bacteria that resemble small tightly coiled 
spirals. Its organisms are known to cause abortion in sheep and fever and enteritis in man 
and may be associated with enteric diseases of calves, lambs, and other animals. 
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Campylobacter rectus (C. rectus): A species of Campylobacter spp. isolated from cases 
of human periodontitis. It is a microaerophile, capable of respiring with OXYGEN.  
Carboxymethylcellulose (CMC): A cellulose derivative which is a beta-(1,4)-D-
glucopyranose polymer. It is used as a bulk laxative and as an emulsifier and thickener in 
cosmetics and pharmaceuticals and as a stabilizer for reagents. 
CD14 (Cluster of differentiation 14): Glycolipid-anchored membrane glycoproteins 
expressed on cells of the myelomonocyte lineage including monocytes, macrophages, and 
some granulocytes. They function as receptors for the complex of lipopolysaccharide 
(LPS) and LPS-binding protein. 
Cytokeratin 7: A class of fibrous proteins or scleroproteins that represents the principal 
constituent of epidermis. Type 7 is a type II keratin found associated with ductal 
epithelia, gastrointestinal epithelia and trophoblasts. 
Chorioamnionitis: Inflammation of the placental membranes (chorion, amnion) and 
connected tissues such as fetal blood vessels and umbilical cord. It is often associated 
with intrauterine ascending infections during pregnancy. 
Choriocarcinoma: A malignant metastatic form of trophoblastic tumors. 
Chronic Periodontitis: Chronic inflammation and loss of periodontium that is associated 
with the amount of dental plaque or dental calculus present. 
Cyclooxygenase 2: An inducibly-expressed subtype of prostaglandin-endoperoxide 
synthase. It plays an important role in many cellular processes and inflammation. 
DNA, Complementary (cDNA): Single-stranded complementary DNA synthesized from 
an RNA template by the action of RNA-dependent DNA polymerase. cDNA (i.e., 
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complementary DNA, not circular DNA, not C-DNA) is used in a variety of molecular 
cloning experiments as well as serving as a specific hybridization probe. 
Endometrium: The mucous membrane lining of the uterine cavity that is hormonally 
responsive during the menstrual cycle and pregnancy. 
Escherichia coli (E. coli): A species of gram-negative, facultative anaerobic, rod-shaped 
bacteria commonly found in the lower part of the intestine of warm-blooded animals. 
Fetal Growth Restriction (FGR or IUGR): The failure of a fetus to attain its expected 
fetal growth at any gestational age. 
Fetal Membranes (Premature Rupture, PROM, PPROM): Spontaneous tearing of the 
membranes surrounding the fetus any time before the onset of obstetric labor. Preterm 
PROM is membrane rupture before 37 weeks of gestation. 
Fetal Weight: The weight of the fetus in utero. It is usually estimated by various 
formulas based on measurements made during prenatal ultrasonography. 
Fluorescent Antibody Technique: Test for tissue antigen using either a direct method, 
by conjugation of antibody with fluorescent dye or an indirect method, by formation of 
antigen-antibody complex which is then labeled with fluorescein-conjugated anti-
immunoglobulin antibody. The tissue is then examined by fluorescence microscopy. 
Fusobacterium nucleatum (F. nucleatum): A species of gram-negative, anaerobic, rod-
shaped bacteria isolated from the gingival margin and sulcus and from infections of the 
upper respiratory tract and pleural cavity. 
Gene Expression: The phenotypic manifestation of a gene or genes by the processes of 
genetic transcription and genetic translation. 
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Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH): An NAD-dependent 
glyceraldehyde-3-phosphate dehydrogenase found in the cytosol of eukaryotes. It 
catalyzes the dehydrogenation and phosphorylation of Glyceraldehyde 3-phosphate to 3-
phospho-D-glyceroyl phosphate, which is an important step in the glycolysis pathway. Its 
mRNA gene is commonly used as a housekeeping gene activity reference. 
Gram-Negative Anaerobic Bacteria: A large group of anaerobic bacteria which show 
up as pink (negative) when treated by the Gram-staining method. 
Granulocyte Colony-Stimulating Factor(GCSF): A glycoprotein of MW 25 kDa 
containing internal disulfide bonds. It induces the survival, proliferation, and 
differentiation of neutrophilic granulocyte precursor cells and functionally activates 
mature blood neutrophils. Among the family of colony-stimulating factors, G-CSF is the 
most potent inducer of terminal differentiation to granulocytes and macrophages of 
leukemic myeloid cell lines. 
Hematoxylin and eosin (H&E stain): HE stain or hematoxylin and eosin stain is a 
staining method in histology. 
Host-Pathogen Interactions: The interactions between a host and a pathogen, usually 
resulting in disease. 
Immunoglobulin G: The major immunoglobulin isotype class in normal human serum. 
There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. 
Immunoglobulin M: A class of immunoglobulin bearing mu chains. IgM can fix 
complement. The name comes from its high molecular weight and originally being called 
a macroglobulin. 
 xix 
 
Interleukin-6 (IL-6): A cytokine that stimulates the growth and differentiation of B-
lymphocytes and also mainly acts as a pro-inflammatory cytokine. 
Kaplan-Meiers Estimate: A nonparametric method of compiling life tables or survival 
tables. It combines calculated probabilities of survival and estimates to allow for 
observations occurring beyond a measurement threshold, which are assumed to occur 
randomly. Time intervals are defined as ending each time an event occurs and are 
therefore unequal. 
Labor, Premature: Onset of obstetric labor before term (term birth) but usually after the 
fetus has become viable. In humans, it occurs sometime during the 29th through 37th 
week of pregnancy. 
Lipopolysaccharide (LPS): Lipid-containing polysaccharides which are endotoxins and 
important group-specific antigens. They are often derived from the cell wall of gram-
negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule 
consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O 
ANTIGENS). 
Matrix Metalloproteinases (MMPs): Matrix metalloproteinases that are associated with 
the cell membrane, either through transmembrane domains or 
Glycosylphosphatidylinositol anchors. Membrane-type matrix metalloproteinases may 
act within the pericellular environment to influence the process of cell migration. 
Mice, Inbred strains: Genetically identical individuals developed from brother and sister 
matings which have been carried out for twenty or more generations, or by parent x 
offspring matings carried out with certain restrictions. All animals within an inbred strain 
trace back to a common ancestor in the twentieth generation. 
 xx 
 
Mice, Knockout: Strains of mice in which certain genes of their genomes have been 
disrupted, or "knocked-out". To produce knockouts, using recombinant DNA technology, 
the normal DNA sequence of the gene being studied is altered to prevent synthesis of a 
normal gene product. Cloned cells in which this DNA alteration is successful are then 
injected into mouse embryos to produce chimeric mice. The chimeric mice are then bred 
to yield a strain in which all the cells of the mouse contain the disrupted gene. 
Multiplicity of infection (MOI):  ratio of infectious agents (e.g. phage or virus) to 
infection targets (e.g. cell). For example, when referring to a group of cells inoculated 
with infectious virus particles, the multiplicity of infection or MOI is the ratio defined by 
the number of infectious virus particles deposited in a well divided by the number of 
target cells present in that well. 
Natural Killer Cells (NK cells): Bone marrow-derived lymphocytes that possess 
cytotoxic properties, classically directed against transformed and virus-infected cells. NK 
cells are not antigen specific. The cytotoxicity of natural killer cells is determined by the 
collective signaling of an array of inhibitory and stimulatory cell surface receptors. 
NF-kappa B (NF-kB): Ubiquitous, inducible, nuclear transcriptional activator that binds 
to enhancer elements in many different cell types and is activated by pathogenic stimuli. 
The NF-kappa B complex is a heterodimer composed of two DNA-binding subunits: NF-
kappa B1 and relA. 
Pathogen-associated molecular patterns (PAMPs): are molecules associated with 
groups of pathogens, that are recognized by cells of the innate immune system. These 
molecules can be referred to as small molecular motifs conserved within a class of 
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microbes. They are recognized by Toll-like receptors (TLRs) and other pattern 
recognition receptors (PRRs) in both plants and animals. 
Pattern recognition receptors (PRRs): A large family of cell surface receptors that bind 
conserved molecular structures present in pathogens. They play important roles in host 
defense by mediating cellular responses to pathogens. 
Periodontal Diseases: Pathological processes involving the periodontium including the 
gum (gingiva), the alveolar bone (alveolar process), the dental cementum, and the 
periodontal ligament. 
Placenta: A highly vascularized mammalian fetal-maternal organ and major site of 
transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion 
(chorionic villi) derived from trophoblasts and a maternal portion (decidua) derived from 
the uterine endometrium. 
Porphyromonas gingivalis (P. gingivalis): A species of gram-negative, anaerobic, rod-
shaped bacteria originally classified within the bacteroides genus. This bacterium 
produces a cell-bound, oxygen-sensitive collagenase and is isolated from the human 
mouth. 
Pre-Eclampsia: A complication of pregnancy, characterized by a complex of symptoms 
including maternal hypertension and proteinuria with or without pathological edema. Pre-
eclampsia usually occurs after the 20th week of gestation, but may develop before this 
time in the presence of trophoblastic disease. 
Pregnancy Complications: Conditions or pathological processes associated with 
pregnancy. They can occur during or after pregnancy, and range from minor discomforts 
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to serious diseases that require medical interventions. They include diseases in pregnant 
females, and pregnancies in females with diseases. 
Pregnancy Outcome: Results of conception and ensuing pregnancy, including live birth; 
stillbirth; spontaneous abortion; induced abortion. 
Preterm Delivery (PTD): childbirth before 37 weeks of pregnancy (259 days from the 
first day of the mother's last menstrual period, or 245 days after fertilization). 
RNA, Messenger: RNA sequences that serve as templates for protein synthesis. Bacterial 
mRNAs are generally primary transcripts in that they do not require post-transcriptional 
processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the 
cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid 
at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for 
certain, but it may play a role in the export of mature mRNA from the nucleus as well as 
in helping stabilize some mRNA molecules by retarding their degradation in the 
cytoplasm. 
Survival Analysis: A class of statistical procedures for estimating the survival function 
(function of time, starting with a population 100% well at a given time and providing the 
percentage of the population still well at later times). The survival analysis is then used 
for making inferences about the effects of treatments, prognostic factors, exposures, and 
other covariates on the function. 
Toll-Like Receptors (TLRs): A family of pattern recognition receptors characterized by 
an extracellular leucine-rich domain and a cytoplasmic domain that share homology with 
the Interleukin 1 receptor and the Drosophila toll protein. Following pathogen 
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recognition, toll-like receptors recruit and activate a variety of signal transducing adaptor 
proteins. 
Toll-Like Receptor 4 (TLR4): A pattern recognition receptor that interacts with 
lymphocyte antigen 96 and lipopolysaccharides. It mediates cellular responses to GRAM 
negative bacteria. 
Trophoblasts: Cells lining the outside of the blastocysts. After binding to the 
endometrium, trophoblasts develop into two distinct layers, an inner layer of 
mononuclear cytotrophoblasts and an outer layer of continuous multinuclear cytoplasm, 
the syncytiotrophoblasts, which form the early fetal-maternal interface (placental). 
Tumor Necrosis Factor-alpha (TNF-α): Serum glycoprotein produced by activated 
macrophages and other mammalian mononuclear leukocytes. It has necrotizing activity 
against tumor cell lines and increases ability to reject tumor transplants. Also known as 
TNF-alpha, it is only 30% homologous to TNF-beta (Lymphotoxin), but they share TNF 
receptors. 
World Health Organization: A specialized agency of the United Nations designed as a 
coordinating authority on international health work; its aim is to promote the attainment 
of the highest possible level of health by all peoples. 
Kruskal-Wallis H Statistic: A class of statistical methods applicable to a large set of 
probability distributions used to test for correlation, location, independence, etc. In most 
nonparametric statistical tests, the original scores or observations are replaced by another 
variable containing less information. 
  
 
 
1. Chapter 1. Introduction  
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Preterm delivery (PTD): Epidemiology and definitions 
Preterm delivery is the major cause of neonatal mortality and morbidity and is 
associated with short-term (low birth weight) and long-term adverse sequelae 
(cerebral palsy, hearing and learning problems)(MacDorman et al. 2005). The World 
Health Organization defines PTD as birth at less than 37 completed gestational 
weeks(1970); however, an additional definition of very preterm delivery (birth at <32 
weeks) has been proposed based on higher morbidity/mortality associated 
rates(Kramer et al. 2000). The prevalence of PTD around the world ranges from 5-9% 
in Europe, 12-13% in the USA (Figure 1.1) and up to 34% in India(Goldenberg et al. 
2008, Ananth & Vintzileos 2006). Broadly speaking, preterm deliveries are believed 
to account for up to 75-85% of the early neonatal deaths not due to lethal congenital 
deformities around the world(2004, McCormick 1985). In the United States, 
extremely preterm infants have been reported to account for 49%-58% of neonatal 
deaths during 1989-2001 accompanied by significant racial/ethnic associated factors 
such as lack of prenatal care or social support, stress and bacterial vaginosis. Notably, 
USA neonatal death rates have declined over the last decades, probably due to 
medical advances such as surfactant therapy (to improve infant lung maturity), folic 
acid consumption (to reduce neural tube defects) and antimicrobial therapy (to control 
infectious episodes during pregnancy)(Simcox et al. 2007). In fact, Preventive 
therapies with antibiotics have emerged as a prophylactic strategy to decrease PDT 
rates in industrialized countries; however there is conflicting evidence coming from 
randomized clinical trials evaluating the real benefits of antibiotic intake by pregnant 
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women(Laudanski et al. 2007). Researchers have proposed that the contradictory 
results could be related to the fact that some human subclinical infections do not 
respond well to wide-spectrum antimicrobial therapy, raising the possibility that 
common non-treated infections (including periodontal disease) may play a role in 
PTD pathogenesis(Vidaeff & Ramin 2006, Offenbacher et al. 1996). 
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Figure 1.1 Percentage of all births classified as preterm in the USA, 1981-2004. 
 
 
 
Despite recent advances in the understanding of preterm delivery, there is an increase 
in the proportions of preterm birth (%) in the last 20 years. Adapted from 
(Goldenberg et al. 2008). Source: Martin JA, Kochanek KD, Strobino DM, Guyer B, 
MacDorman MF. Annual summary of vital statistics—2003. Pediatrics 2005; 115: 
619–34.   
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PTD pathogenesis: infection, inflammation and the role of placental Toll like 
receptors 
Preterm delivery can be initiated by multiple mechanisms including infection, 
local inflammation, uteroplacental ischemia, hemorrhage, stress and other 
immunologically mediated processes(Romero et al. 2006). Even though the precise 
triggering mechanism has not been established, the development of a 
proinflammatory condition is a common pathway that centralizes all multiple risk 
factors(Romero et al. 1994) (Figure 1.2). Histologically, local inflammatory features 
at the fetoplacental unit are termed as chorioamnionitis, (initially confined at the 
choriodecidual level) which activate the decidua
 
and the fetal membranes to produce 
a number of cytokines, including
 
Tumor Necrosis factor alpha (TNF-α), Interleukin-1 
beta (IL-1β), Interleukin-6 (IL-6), Interleukin-8 (IL-8), and Granulocyte Colony-
stimulating
 
factor (GCSF)(Gomez et al. 1997). These cytokines stimulate 
prostaglandins synthesis/release and also initiate neutrophil chemotaxis, infiltration,
 
and activation. The inflammatory process continues with the synthesis and release of
 
metalloproteinases (MMP’s) and other bioactive substances; the prostaglandins 
stimulate uterine contractions while the MMP’s degrades the chorioamniotic 
membranes, leading to either spontaneous preterm labor with intact membranes or 
preterm premature rupture of the membranes-PPROM(Goldenberg et al. 2000). 
Particularly, uterine infections account for 25–40% of preterm births and they 
are strongly linked with the inflammatory pathway onset. Uterine infections are 
known to upregulate the production of local pro-inflammatory cytokines, 
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 Figure 1.2 The pathogenesis of human preterm delivery. 
 
 
 
Model proposed by (Gomez et al. 1997). The authors proposed that the initiation of 
human parturition in the presence of infection is controlled by the host. Systemic 
maternal infections such as pyelonephritis or localized infections such as deciduitis 
can trigger parturition by the activation of the monocyte and macrophage system in 
peripheral blood and human decidua. Preterm labor can be the result of events that 
occur when the intrauterine or maternal environment is hostile and threaten the 
survival of the fetal-maternal pair. Preterm labor and preterm premature rupture of 
membranes (PPROM) can be considered expressions of the same basic phenomenon: 
activation of the host-defense macrophage system. Adapted from Gomez R, Romero 
R, Edwin SS, David C. Pathogenesis of preterm labor and preterm premature rupture 
of membranes associated with intraamniotic infection. Infect Dis Clin North Am 1997 
11(1):135-76.  
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 metalloproteinases and prostaglandins that lead to membrane weakening, 
early membrane rupture and uterine contraction initiation(Shoji et al. 2007). Uterine 
infections usually take advantage of ascending mechanisms, which can be described 
briefly in three different stages: the first stage consists of an overgrowth of anaerobic 
microorganisms or the presence of pathologic organisms (i.e., Neisseria gonorrhoeae 
or Ureaplasma urealyticum) in the vagina and cervix. Bacterial vaginosis may be an 
early manifestation of stage 1. Once microorganisms ascend and gain access to the 
intrauterine cavity, they may reside and colonize the decidua (stage 2). A localized 
inflammatory reaction leads to deciduitis and spreads to chorionitis. The infection 
may invade the fetal vessels (choriovasculitis) or proceed through the amnion 
(amnionitis) into the amniotic cavity and lead to an intraamniotic infection (stage 3). 
The most advanced and serious stage of ascending intrauterine infection is fetal 
infection (stage 4)(Gomez et al. 1997). 
If placental tissues ultimately present an inflammatory phenotype in response 
to multiple PTD-associated triggering factors, then proinflammatory responses are 
likely to be initiated by the host innate immune system. Toll-like receptors (TLRs) are 
a family of transmembrane proteins that have a primary role in pathogen recognition 
and innate immunity initiation(Brikos & O'Neill 2008). TLRs receptors bind to 
several microbial components or end-products known as pathogen-associated 
molecular patterns (PAMPs), which include peptidoglycans, lipoteichoic acid, 
flagellin, double-stranded viral RNA, unmethylated bacterial DNA and 
lipopolysaccharide (LPS) among others (Table 1.1). After binding and recognition,  
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Table 1-1 Summary of known mammalian TLRs. 
 
Adapted from Waltenbaugh C, Doan T, Melvold R, Viselli S (2008). Immunology. 
Lippincott's Illustrated reviews. Philadelphia: Wolters Kluwer Health/Lippincott 
Williams & Wilkins. pp. 17.  
Receptor Ligand(s) Ligand location Adapter(s) Location Cell types
monocytes/macro
phages
a subset 
of dendritic cells
B lymphocytes
multiple glycolipids Bacteria
monocytes/macro
phages
multiple lipopeptides Bacteria
Myeloid dendritic 
cells[19]
multiple lipoproteins Bacteria Mast cells
lipoteichoic acid Bacteria
HSP70 Host cells
zymosan (Beta-glucan) Fungi
Numerous others
Dendritic cells
B lymphocytes
lipopolysaccharide
Gram-negative 
bacteria
monocytes/macro
phages
several heat shock 
proteins
Bacteria and host 
cells
Myeloid 
dendritic 
cells[19]
fibrinogen host cells Mast cells
heparan 
sulfate fragments
host cells
Intestinal 
epithelium
hyaluronic 
acid fragments
host cells
nickel
Numerous others
monocyte/macrop
hages
a subset of 
dendritic cells
Intestinal 
epithelium
monocytes/macro
phages
Mast cells
B lymphocytes
imidazoquinoline
monocytes/macro
phages
loxoribine (a guanosine 
analogue)
Plasmacytoid 
dendritic cells
bropirimine B lymphocytes
single-stranded RNA
monocytes/macro
phages
a subset of 
dendritic cells
Mast cells
monocytes/macro
phages
Plasmacytoid 
dendritic cells
B lymphocytes
monocytes/macro
phages
B lymphocytes
monocytes/macro
phages
liver cells
kidney
urinary 
bladder epithelium
TLR 11 Profilin
Toxoplasma gon
dii
MyD88
cell 
compartment
TLR 9
unmethylated CpG 
Oligodeoxynucleotide
 DNA
Bacteria MyD88 cell compartment
TLR 10 unknown unknown unknown cell surface
TLR 7
small synthetic 
compounds MyD88 cell compartment
TLR 8
small synthetic 
compounds; single-
stranded RNA
MyD88 cell compartment
TLR 5 flagellin Bacteria MyD88 cell surface
TLR 6
multiple diacyl 
lipopeptides
Mycoplasma MyD88/MAL cell surface
TLR 3
double-stranded 
RNA, poly I:C
viruses TRIF cell compartment
TLR 4
MyD88/MAL/TRI
F/TRAM
cell surface
TLR 1
multiple 
triacyl lipopeptides
Bacteria MyD88/MAL cell surface
TLR 2 MyD88/MAL cell surface
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TLRs are able to trigger an array of signaling pathways that ultimately 
activate downstream molecules such as nuclear factor kB (NF-kB) and interferon 
regulatory factor 3 (IRF-3)(Uematsu & Akira 2006), which in turn mediate the 
expression of several proinflammatory cytokines as demonstrated in several tissues, 
including the maternal-fetal interface(Koga & Mor 2008). TLRs are highly involved 
in responding to inflammatory processes in the presence or absence of infection. In 
particular, TLRs are thought to be a critical component of the innate immune 
response during pregnancy, which have significant implications for the success or 
failure of pregnancies in both early and late gestation(Patni et al. 2007). To date, 13 
mammalian Toll-like receptors homologues have been identified and designated 
(Table 1.1), and their expression has been described in the human placenta, mostly at 
the dominant cell type: the trophoblast(Abrahams et al. 2004, Holmlund et al. 2002, 
Kumazaki et al. 2004). Trophoblasts are the first cells to differentiate from the outer 
layer of the blastocyst, which are believed to be in charge of endometrial implantation 
and placental development(Cohen & Bischof 2007). Nonetheless, trophoblasts have 
also been proposed to be involved in coordinating the immune response during both 
processes(Mor 2008). For example, trophoblast are believed to regulate immune cells 
migration (macrophages and NK cells) to the endometrial implantation site by means 
of TLRs activation and subsequent chemokines production(Abrahams et al. 2005); 
abnormalities in decidual TLRs expression or function have been linked to abnormal 
placentation, inflammation, and adverse pregnancy outcomes(Krikun et al. 2007). 
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While TLRs are nowadays recognized to play an important role in the 
regulation of immune responses during pregnancy, the factors that regulate and affect 
TLR expression and function are poorly understood. Even though TLRs widely 
participate in placental immunological surveillance, the fact that specific toll like 
receptors or associated pathways prevail during placental inflammation may give new 
insights in understanding PTD pathogenesis. The selective activation of specific 
TLRs and TLR-associated pathways in response to local infection to several 
pathogens, including bacteria of oral origin, may bring new ideas in therapeutic 
interventions in the near future.  
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The Association of Periodontal disease and preterm delivery 
Periodontal disease (gingivitis and periodontitis) is one of the most common 
chronic infections affecting up to 50% of humans(Albandar 2002). Periodontitis is 
initiated when specific microorganisms accumulate between the teeth and gums, 
forming bacterial biofilms commonly known as dental plaque. The body reacts to 
dental biofilms by activating a local inflammatory response that -at some susceptible 
patients- is unsuccessful in controlling or eliminating the infection. With time, the 
inflammatory response remains chronic and ultimately leads to periodontal 
connective tissue resorption (alveolar bone loss) and tooth loss(Madianos et al. 2005). 
Periodontal disease is not closely associated with pain experience, and 
patients usually carry the disease for several years until noticing end-stage clinical 
signs (discomfort, breath malodor, gingival bleeding and tooth mobility)(Gilbert & 
Nuttall 1999, Pitiphat et al. 2002, Cunha-Cruz et al. 2007). Hence, the characteristic 
―silent‖ and chronic nature of periodontitis has led investigators to hypothesize that 
the disease course may serve as a chronic focal infection source for different systemic 
diseases(Li et al. 2000). In particular, periodontal diseases have been found to be an 
independent risk factor for pregnancy-related complications like preterm delivery, 
low birth weight and preeclampsia, after adjusting for other known obstetric risk 
factors(Riche et al. 2002, Offenbacher et al. 2006, Lin et al. 2007, Contreras et al. 
2006, Scannapieco et al. 2010) (Figure 1.3). During the prolonged oral inflammatory 
response, periodontopathogenic bacteria and related virulence factors invade
 Figure 1.3 Published studies on the association between periodontal disease and pregnancy outcomes 
.  
Adapted from (Scannapieco et al. 2010).
 periodontal tissues, enter the blood stream by means of transient bacteremias(Lafaurie 
et al. 2007) and disseminate throughout systemic organs. In fact, important 
periodontal pathogens including Porphyromonas gingivalis have been detected in 
atherosclerotic plaques(Chiu 1999, Ford et al. 2006, Haraszthy et al. 2000, Fiehn et 
al. 2005, Kozarov et al. 2006) and in the amniotic fluid of pregnant women with a 
diagnosis of threatened premature labor(Leon et al. 2007).  
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Campylobacter species and their role in uterine and oral infections 
Translocation of oral bacteria to the developing fetus has also been 
demonstrated in umbilical cord blood samples from preterm deliveries by detecting 
maternal immunoglobulin G (IgG) as well as fetal immunoglobulin M (IgM) to one 
or more specific oral pathogens. In particular, Campylobacter rectus has been 
reported to be significantly prevalent in preterm deliveries based on low maternal IgG 
and high fetal IgM titers(Madianos et al. 2001), suggesting that C. rectus could act as 
a fetal infectious agent eliciting prematurity. C. rectus is an orally-exclusive Gram 
negative anaerobe and motile bacterium that plays a pathogenic role in human 
periodontitis(Rams et al. 1993, Yokoyama et al. 2008). Campylobacter species show 
a wide array of virulence factors including surface layer (S-layer) proteins(Miyamoto 
et al. 1998, Thompson 2002) (involved in phagocytic and bactericidal resistance); 
cytolethal distending toxin (CDT)(Gillespie et al. 1993) and RTX proteins(Braun et 
al. 1999) (pore-forming protein toxins similar to hemolysins and leucotoxins); 
GroEL-like proteins(Hinode et al. 1998) (heat-sock protein activity), flagella 
(motility) and lipopolysaccharide (LPS)(Ogura et al. 1995, Ogura et al. 1996, 
Takiguchi et al. 1996). Interestingly, C. rectus is part of the Campylobacteraceae 
family which has been associated with other diseases showing important mechanistic 
similarities: for example, Campylobacter jejuni is the most common causal agent of 
acute gastroenteritis (diarrhea) in the USA(Allos 2001) and Campylobacter fetus is a 
significant causal agent of sheep and cattle abortion due to a marked tropism for 
placental tissues(Guerrant et al. 1978, Macuch & Tanner 2000, Fujihara et al. 2006). 
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In animal models, C jejuni and C. fetus infections result in impaired fetal 
development and intrauterine growth restriction(O'Sullivan et al. 1988a, O'Sullivan et 
al. 1988b). Noteworthy, our in vivo C. rectus infection experiments in pregnant mice 
have consistently shown maternal inflammatory serum markers upregulation, 
dissemination to placental tissues and consequent fetal intrauterine growth 
restriction(Offenbacher et al. 2005, Yeo et al. 2005) and placental structural 
alterations as well as important gene expression changes(Bobetsis et al. 2007). 
 
In summary, the evidence here discussed suggest that periodontal disease may 
facilitate the oral-fetal hematogenous translocation of oral pathogens probably due to 
increased bacterial load in the oral cavity, the altered immune response in the 
susceptible host and the chronic inflammatory disease course. In addition, the oral 
pathogen Campylobacter rectus shows important virulence factors that may elicit 
prematurity in humans. Therefore, we believe that periodontal disease and related 
pathogens have unique features that are linked to pregnancy complications and the 
research here presented will lead to new knowledge, insights, theories and health 
policies in the preterm delivery field in the upcoming future. 
  
 
 
2. Chapter 2.  Increased TLR4 expression in murine placentas after oral 
infection with periodontal pathogens.  
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Abstract 
.Maternal periodontitis has emerged as a putative risk factor for preterm births 
in humans. The periodontitis-associated dental biofilm is thought to serve as an 
important source of oral bacteria and related virulence factors that hematogenously 
disseminate and affect the fetoplacental unit; however the underlying biological 
mechanisms are yet to be fully elucidated. This study hypothesized that an oral 
infection with the human periodontal pathogens Campylobacter rectus and 
Porphyromonas gingivalis is able to induce fetal growth restriction, placental 
inflammation and enhance Toll-like receptors type 4 (TLR4) expression in a murine 
pregnancy model. Female Balb/C mice (n = 40) were orally infected with C. rectus 
and/or P. gingivalis over a 16-week period and mated once/week. Pregnant mice were 
sacrificed at embryonic day (E) 16.5 and placentas were collected and analyzed for 
TLR4 mRNA levels and qualitative protein expression by real-time PCR and 
immunofluorescence. TLR4 mRNA expression was found to be increased in the C. 
rectus-infected group (1.98 +/- 0.886-fold difference, P < 0.01, ANOVA) compared 
to controls. Microscopic analysis of murine placentas showed enhanced 
immunofluorescence of TLR4 in trophoblasts, mainly in the placental labyrinth layer. 
Also, combined oral infection with C. rectus and P. gingivalis significantly reduced 
the overall fecundity compared to controls (16.7% vs. 75%, infected vs. non-infected 
mice respectively, P = 0.03, Kaplan-Meier). The results supported an enhanced 
placental TLR4 expression after oral infection with periodontal pathogens. The TLR4 
pathway has been implicated in the pathogenesis of preterm births; therefore the 
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abnormal regulation of placental TLR4 may give new insights into how maternal 
periodontitis and periodontal pathogens might be linked to placental inflammation 
and preterm birth pathogenesis.  
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Introduction 
Preterm birth (birth at ≤37 completed gestational weeks) is the major cause of 
neonatal mortality/morbidity in the world, accounting for up to 75-85% of the early 
neonatal deaths as well as to high rates of short-term (low birth weight) and long-term 
adverse sequelae (hearing/learning problems and cerebral palsy) (McCormick 1985). 
The pathogenesis of preterm birth is thought to be multi-factorial, possibly initiated 
by multiple mechanisms including infection, uteroplacental ischemia, hemorrhage, 
stress and other immunologically mediated processes (Romero et al. 2006); however, 
the development of a pro-inflammatory condition is a common effector pathway that 
centralizes all multiple risk factors (Romero et al. 1994). In particular, uterine 
infections may account for 25–40% of preterm births and they are strongly linked 
with a pro-inflammatory systemic state. For example, uterine infections are known to 
upregulate the production of local pro-inflammatory cytokines, metalloproteinases 
and prostaglandins that lead to membrane weakening, early membrane rupture and 
uterine contraction initiation (Shoji et al. 2007). Uterine infections usually take 
advantage of ascending mechanisms, which are originated from vaginal infections 
(i.e. Neisseria gonorrhoeae or Ureaplasma urealyticum) that lead to intrauterine 
cavity access, decidua colonization, localized inflammation onset (or 
chorioamnionitis), intraamniotic infection and ultimately fetal infection (Gomez et al. 
1997). 
Nonetheless, other sources of infection including the oral cavity have been 
proposed to facilitate the hematogenous transmission of pathogens that affect normal 
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pregnancy development (Hill 1998). In particular, periodontal diseases (gingivitis and 
periodontitis) are part of the most common chronic infections affecting up to 50% of 
humans (Albandar 2002) and has been found to be an independent putative risk factor 
for pregnancy-related complications such as preterm births, low birth weight and 
preeclampsia, after adjusting for other known obstetric risk factors (Offenbacher et al. 
2006, Contreras et al. 2006). Periodontitis is initiated when specific microorganisms 
accumulate between the teeth and gums, forming bacterial biofilms commonly known 
as dental plaque. The body reacts to dental biofilms by activating the oral mucosal 
inflammatory response that –in some susceptible patients- is unsuccessful in 
controlling the infection. With time, the inflammatory response remains chronic and 
ultimately leads to periodontal connective tissue resorption (alveolar bone loss) and 
tooth loss (Madianos et al. 2005). During prolonged periodontal inflammation, 
periodontal pathogens and related virulence factors invade periodontal tissues, enter 
the blood stream by means of transient bacteremias (Forner et al. 2006) and 
disseminate throughout different systemic organs. In fact, important periodontal 
pathogens have been detected in human placentas of women with preeclampsia 
(Barak et al. 2007) and in the amniotic fluid of pregnant women with a diagnosis of 
premature labor (Leon et al. 2007) or premature labor with intact membranes (Chaim 
& Mazor 1992, Gardella et al. 2004). 
Fetal exposure to periodontal pathogens from maternal oral biofilms has also 
been demonstrated in umbilical cord blood samples from preterm births by detecting 
maternal immunoglobulin G (IgG) as well as fetal immunoglobulin M (IgM) to one 
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or more specific oral pathogens. In particular, mothers with a low IgG response to P. 
gingivalis combined with a high fetal IgM response to C. rectus showed the highest 
rate of preterm deliveries (66.7%) among 812 deliveries from a cohort study of 
pregnant mothers (adjusted OR 10.3; P<0.0001) (Madianos et al. 2001), suggesting 
that P. gingivalis and C. rectus could act as fetal infectious agents eliciting 
complications during pregnancy. C. rectus is an Gram negative anaerobe and motile 
bacterium unique to the oral cavity that is phylogenetically related to H. pylori and is 
associated with ulceration of the periodontal attachment apparatus (Rams et al. 1993). 
Interestingly, other Campylobacter species are known to be a significant causal agent 
of sheep and cattle abortion due to a marked tropism for placental tissues (Fujihara et 
al. 2006). In animal models, C jejuni and C. fetus infections result in impaired 
development and fetal growth restriction (FGR) (O'Sullivan et al. 1988b).We have 
previously reported that a subcutaneous infection with C. rectus in pregnant mice 
disseminates to placental tissues and induces FGR (Offenbacher et al. 2005, Yeo et al. 
2005), placental inflammation and structural alterations. (Bobetsis et al. 2007). 
Likewise, animal experiments using Porphyromonas gingivalis in a subcutaneous 
infection model have shown increased maternal inflammatory serum markers 
(Interleukin-6 and tumor necrosis factor alpha TNF-α), and increased fetal 
biochemical markers of placental inflammation (prostaglandin E2) in murine amniotic 
fluid (Lin et al. 2003b, Lin et al. 2003a). 
Placental infection and subsequent inflammation have been associated with 
preterm labor, so the biological pathways related to early inflammatory responses are 
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likely to mediate pathogenesis. Toll-like receptors (TLRs) are pattern recognition 
receptors that play a key role in the innate inflammatory response (Uematsu & Akira 
2006) and have been proposed to play important roles in pregnancy maintenance, 
placental immune protection and delivery initiation (Patni et al. 2007). To date, a total 
of 10 human and 12 murine TLRs have been described. In general, TLRs can be 
categorized into two main groups based on their ligands: the first group consists of 
TLR1, 2, 4, and 6 which recognize bacterial molecules such as lipopolysaccharide 
(LPS), lipoteichoic acid and peptidoglycan. The second group consists of TLR3, 7, 8, 
and 9 that recognize pathogen-associated nucleic acids patterns (Brikos & O'Neill 
2008). Here in we focused on TLR4 which is selectively activated by Gram negative 
LPS, in conjunction with CD14 (Pandey & Agrawal 2006). Since P. gingivalis and C. 
rectus are Gram negative periodontal pathogens, the main objective of this study was 
to determine whether an oral infection with C. rectus and C. rectus/P. gingivalis 
combined infection could affect fetal growth, fecundity and induce placental 
inflammation along with enhanced expression of TLR4 in a timed-pregnancy murine 
model.  
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Materials and Methods 
Timed-pregnancy murine model: Balb/C mice were obtained at 6-8 weeks 
of age and maintained on a 12-h light/dark cycle (0700 to 1900 light) and a constant 
temperature of 25°C, receiving distilled water and food ad libitum. To facilitate 
bacterial colonization, all female groups were changed to a soft chow enriched with a 
dextrose solution (30%) as plaque-promoting diet during infection period. For mating 
purposes, females were age-matched when 20 weeks old, and males were randomly 
assigned to experimental groups and remained the same until the end. Female 
pregnancies were confirmed by the presence of a vaginal plug plus significant weight 
changes (>1.5 grams gain in a week). Mice were infected daily over a 16-week period 
and mated once/week. When pregnant, female mice were sacrificed at embryonic day 
(E) 16.5 and placental tissues were collected and analyzed. All procedures were in 
accordance with animal guidelines and were approved by the University of North 
Carolina at Chapel Hill Institutional Animal Care and Use Committee. 
Bacterial strains and inoculum preparation: C. rectus 314 and P. gingivalis 
A7436 aliquots were maintained in Wilkins Chalgren anaerobic broth medium (WC 
broth; DSMZ, Braunschweig, Germany) containing 10% skim milk at -80°C. C. 
rectus aliquots were reconstituted on PRAS ETSA plates (Enriched Tryptic Soy Agar 
from Anaerobe Systems, Morgan Hill CA) and P. gingivalis aliquots on Anaerobic 
Reducible Blood Agar (from Remel, Lenexa KA). For experiments, bacteria were 
anaerobically grown under 5% CO2, 10% H2-85% N2 atmosphere at 37°C for 4-6 
days. Bacterial suspensions were prepared from primary cultures at their log phase of 
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growth, and concentrations were determined by spectrophotometry (Cecil 
Instruments, Cambridge, UK) with a measured optical density at 600 nm (C. rectus) 
and 660 nm (P. gingivalis) corresponding to 1x10
9
 bacteria/ml respectively. Finally, 
all oral preparations were adjusted accordingly to keep the same concentration during 
oral infection experiments. 
Oral infection protocol: The oral infection model of experimental 
periodontitis has been described elsewhere (Lalla et al. 2003). This model involves a 
pretreatment phase with antibiotics to suppress the oral flora to permit the 
colonization of exogenously applied human oral bacterial strains and the use of 
carboxymethylcellulose (CMC) as a carrier to facilitate bacterial colonization. 
Briefly, before experiment baseline 40 female Balb/C mice were pretreated for 4 days 
with Kanamycin/Ampicillin (50mg/kg-25mg/kg) followed by a 3-day antibiotic wash 
out period, and then randomly assigned to experimental groups (Table 2.1 and Figure 
2.1). Mice were topically infected in the oral cavity with 1x10
10
 live bacterial 
units/100uL in a phosphate-buffered saline (PBS) and 2% CMC preparation on a 
daily basis. Controls included a blank group (same diet without oral infection) and a 
negative control group (CMC application without bacteria). 
Placental histology and Immunofluorescence: Placentas were fixed in 4% 
paraformaldehyde, bisected sagittally, processed and embedded in paraffin. Sections 
(~5 μm) were stained using hematoxylin/eosin (H&E) for structural analysis; other 
sections were processed for immunofluorescence. Briefly, tissue antigens were 
rescued with Safeclear® (Fisher Protocol, Fair Lawn NJ) for 20 minutes and washed 
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Table 2-1 Experimental groups. 
 
 
 
All groups were given ad libitum soft chow enriched with a dextrose solution (30%) 
as a plaque-promoting diet during 16 weeks of experimentation. CMC = 2% 
carboxymethylcellulose in PBS; CFU = colony forming units.  
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Figure 2.1  Experiment timeline. 
 
 
 
Female (3-month old) Balb/C mice were pretreated for 4 days with 
Kanamycin/Ampicillin (50–25 mg/kg) and then randomly assigned to experimental 
groups. Mice were infected daily over a 16-week period and mated once/week. When 
pregnant, mice were sacrificed at embryonic day (E) 16.5 and placental tissues were 
collected and analyzed for TLR4 expression by immunofluorescence (confocal 
microscopy) followed by RT-PCR. Cr=C. rectus; Pg=P. gingivalis.  
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under serial ethanol concentrations. After washing in 0.2% Triton/PBS, 
sections were incubated in 10% non-immune goat serum and bovine serum albumin 
in PBS for 1 hour. Rabbit anti-TLR4 monoclonal antibody (Zymed, Invitrogen, 
Carlsbad CA) and mouse anti-mouse Cytokeratin 7 monoclonal antibody (RCK105 
from Abcam, Cambridge, UK) were incubated overnight on a 1:50 concentration. 
Cytokeratin 7 was chosen as a trophoblast marker following the recommendations of 
the workshop report on cell culture models of trophoblasts (Frank et al. 2000). After 
vigorous washing, secondary biotinylated antibodies were applied for 1 hour (Alexa 
Fluor 568 goat anti-rabbit IgG and Alexa Fluor 488 goat anti–mouse IgG from 
Molecular Probes, Invitrogen, Carlsbad CA) for 1h. Sections were washed in 0.2% 
Triton/PBS, mounted and coverslipped with Vectashield (Vector labs, Burlingame 
CA). All stained sections were analyzed and photographed under confocal 
microscopy (LSM5, Carl Zeiss, Thornwood NY). 
Quantitative RT-PCR for TLR4: Total RNA was isolated from all placental 
tissues (n=135) with the use of the RNeasy Mini Kit (Qiagen). cDNA from 2 µg of 
total RNA was synthesized using the Omniscript Kit (Qiagen) and random decamer 
primers. Real-time PCR was performed with 1 µL cDNA, TaqMan Universal PCR 
mix, and 20X primer (Mm00445273_m1 from Applied Biosystems, Foster City, CA), 
in a 7000 Sequence Detection System (ABI Prism, Applied Biosystems). Reactions 
were performed in duplicates and in two independent times. The Glyceraldehyde-3-
Phosphate Dehydrogenase (GAPDH) gene was used as an endogenous control 
(housekeeping gene). Results were evaluated using the delta-delta Ct method, where 
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delta Ct was calculated as (TLR4 Ct) − (GAPDH Ct), and the relative quantity of 
TLR4 mRNA expression was calculated by the delta–delta Ct as 2−[(infected sample delta 
Ct)−(control sample delta Ct)]
. 
Statistical analysis: A sample size of 8 mice per group was calculated [power 
(1-β) of >0.90% with alpha-error threshold of (α)=0.05)] based on our previous 
results on fetal growth restriction after C. rectus systemic infection (Yeo et al. 2005). 
Categorical variables (number of pregnancies and number of fetuses/resorptions per 
group) were summarized using frequencies and percentages, and continuous variables 
(fetal weight/length and mRNA levels) were described using means and standard 
errors. Distributions of fetuses/resorptions were compared using the Chi-square test. 
Mean fetal weight and length values as well as mRNA levels were compared using 
Analysis of Variance (ANOVA). To determine whether oral infection correlated with 
FGR and resorption induction, a general linear regression model (GLM procedure) 
was used to control for clustering within litters per group. Also, resorptions were 
considered as zero (value=0) to account for their impact on the average litter weight 
and length. Kaplan-Meier estimation analysis was used to evaluate cumulative 
pregnancy events at 16 weeks. Cox proportional hazards ratios were used to 
determine the risk of no pregnancies over time after infection. If no significant 
differences were observed between the control groups (blank and negative), then 
controls were regrouped as non-infected group for analysis. The threshold for 
statistical significance was set at a P-value less than 0.05. All analyses were 
performed using SAS v.9.2. (SAS Institute, Cary, NC).  
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Results 
Oral infection with C. rectus and P. gingivalis induced growth restricted 
fetuses and more fetal resorptions. The murine pregnancy events and fetal 
outcomes after oral infection with periodontal pathogens are depicted in Table 2.2. 
The number of mice which became pregnant during the 16 week infection/mating 
protocol were significantly different among all groups (P<0.05, Chi-square test) as 
well as in the distribution of fetuses and resorptions (P<0.01). On average, fetuses 
from infected mice were smaller and lighter, although fetal lengths were not 
statistically different among all groups (P=0.08, ANOVA). When control groups were 
compared, no significant differences were observed for number of fetuses/resorptions 
[27(96.4%) vs. 41(80.4%), P=0.27, Chi-square], and for fetal weight values 
[0.47±0.012 vs. 0.39±0.035, P=0.87, ANOVA, blank and negative groups 
respectively]. However, when fetal weight values from infected mice were compared 
to those from non-infected mice (regrouped controls), a statistically significant 
decrease was observed for the C. rectus and P. gingivalis infected group (P<0.05, 
ANOVA, Figure 2). Overall, the general linear regression model which adjusted for 
clustering within litters was non-significantly associated with FGR induction (P=0.28, 
GLM procedure). 
Murine fecundity was affected after oral infection. Murine fecundity was 
significantly different among experimental groups (Table 2.3 and Figure 2.2). 68.8% 
of non-infected mice got pregnant; however fecundity decreased to 58.3% in the C. 
rectus infected group and only 16.7% of mice receiving C. rectus and P. gingivalis  
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Table 2-2 Pregnancy events and fetal outcomes after oral infection. 
 
 
 
Distribution of pregnancies, number of fetuses and resorptions were significantly 
different among groups (P < 0.01, Chi-square). Viable fetuses from infected mice 
tended to be smaller and lighter on average, but fetal lengths were not different 
among all groups (P = 0.08, ANOVA). 
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Figure 2.2 Oral infection induces low weight fetuses. 
 
 
 
Averaged fetal weight values from infected mice were smaller when compared to 
those from non-infected mice. Columns and bars represent means and standard errors. 
Cr = C. rectus; Pg = P. gingivalis; *P < 0.05, ANOVA.  
 55 
 
 combined infection got pregnant. When cumulative pregnancies events were 
estimated under Kaplan Meier analysis, it was found that the C. rectus and P. 
gingivalis group had the lowest fecundity rate (Hazard Ratio 0.19[0.041-0.856], 
P=0.03) compared to C. rectus group (HR 0.87[0.310-2.154], P=0.68) and to non-
infected mice (Figure 2.3). 
Oral infection induced placental inflammation and TLR4 expression. 
Figure 4 presents representative histological findings on murine placentas. In the 
control placental tissues, there were scattered inflammatory cells present in the 
maternal decidua of some samples (not shown). In contrast, areas of focal necrosis 
and increased inflammatory cell infiltrate were apparent in placentas from infected 
mice (Figure 2.4A). Under confocal microscopy, the qualitatively analysis of murine 
placentas from infected mice showed enhanced TLR4 immunofluorescence, 
particularly more evident in labyrinth trophoblasts (Figures 2.4B-F). 
Oral infection increased placental TLR4 mRNA expression. In agreement 
with the histological observations, mRNA expression of TLR4 receptors was found to 
be significantly increased in the C. rectus group (1.98±0.886 fold difference, P<0.01 
ANOVA) as shown in Figure 2.5. Even though the TLR4 expression was also higher 
in the C. rectus and P. gingivalis group, no significant differences were observed 
when compared to non-infected mice (1.29±0.871, P=0.06).  
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Figure 2.3 Oral infection affects murine fecundity. 
 
 
Kaplan–Meier analysis. C. rectus and P. gingivalis infected mice had the 
lowest fecundity rate (16.7%, HR 0.19[0.041–0.856], P = 0.03, Kaplan–Meier) 
compared to C. rectus (58.3%, hazard ratio 0.87[0.310–2.154], P = 0.68) and to non-
infected mice.  
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Figure 2.4 Oral infection induced inflammation and TLR4 expression in murine 
placentas. 
 
 
 
Histological and immunofluorescence analysis of murine placentas. A: 
Representative image (H&E stained) depicting extensive junctional zone (JZ) along 
with an increased inflammatory cell infiltrate (arrowheads) in placentas from infected 
mice. Decidua (D); bar = 50 μm. B and C: Immunofluorescence of a placenta from 
the C. rectus and C. rectus/P. gingivalis infected groups respectively. Images 
represent 3 merged channels (Rhodamine, FITC and DIC) depicting trophoblasts 
expressing TLR4 from both groups. D and E: Images depict the expression of 
Cytokeratin 7 (FITC-green) and TLR4 (Rhodamine-red) in labyrinth trophoblasts 
from a different C. rectus-infected section; F: Image illustrates co-localization of 
Cytokeratin 7 and TLR4 suggesting enhanced expression of TLR4 by labyrinth 
trophoblasts. G–I: Images correspond to fluorescence negative controls (no primary 
antibodies used) for Cytokeratin 7 and TLR4 respectively. Rhod = Rhodamine (red); 
FITC = fluorescein isothiocyanate (green); DIC = Differential Interference Contrast; 
white bars = 20 μm  
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Figure 2.5 Oral infection with periodontal pathogens increased TLR4 mRNA 
expression in murine placentas. 
 
 
After normalization, TLR4 mRNA levels were significantly increased in C. rectus 
group placentas (1.98 ± 0.886-fold difference, P < 0.01). Although TLR4 mRNA 
levels were also higher in the combined infection group, no significant differences 
were observed when compared to non-infected mice (1.29 ± 0.871, P = 0.06). Cr = C. 
rectus; Pg = P. gingivalis; *P < 0.01, ANOVA.   
 59 
 
Discussion 
This study sought to determine the effect of C. rectus and C. rectus/P. 
gingivalis oral infection on fetal growth restriction, fecundity and the placental TLR4 
expression in a murine model of pregnancy. Previous experimental murine models of 
infection have examined the role of bacteria and/or isolated virulence factors (i.e. 
LPS) on preterm birth pathogenesis, reporting that C3HeB/FeJ mice develop up to 
71% preterm births after heat-killed E. coli intrauterine injection (Hirsch & Wang 
2005). However not many animal models of infection have addressed the pathogenic 
role of live oral bacterial infection on preterm births. Experiments with live 
periodontal bacteria have used subcutaneously-implanted stainless steel coiled 
chambers as an infection model to study a chronic distant infection in mice and 
rabbits, as it induces placental inflammation and growth restriction phenotypes (C. 
rectus and P. gingivalis) (Boggess et al. 2005a). The periodontal pathogen 
Fusobacterium nucleatum has also been used for intravenous injections in mice, 
showing subsequent placental inflammation and increased fetal resorptions and 
stillbirths (Han et al. 2004). Systemic bacterial dissemination of periodontal 
pathogens has been evidenced in blood, liver, uteri and individual placentas of 
growth-restricted fetuses (Lin et al. 2003b, Lin et al. 2003a, Bobetsis et al. 2007, 
Offenbacher et al. 2005, Yeo et al. 2005). This report provides evidence that the 
mixed oral infection model with C. rectus and P. gingivalis induces FGR and 
resorptions together with histological evidence of placental inflammation with areas 
of focal necrosis, enhanced TLR expression and impaired fecundity. 
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The oral infection model did not significantly correlate with FGR induction, 
conversely to our previous observations using the chamber model of infection (Yeo et 
al. 2005). This finding might be explained in part by the murine immune system 
ability to fight the oral infection, decreasing bacterial systemic dissemination and 
exposure protecting the developing fetuses. Particularly, Baker et al. reported that 
Balb/C mice are able to produce high titers of P. gingivalis-specific IgG using the 
same model of oral infection (Baker et al. 1994) and we have previously reported that 
fetal and placental growth may be unaffected in heat killed-P. gingivalis pre-
immunized rabbits (Boggess et al. 2005b). In addition, the presence of C. rectus or P. 
gingivalis DNA was not detected in placentas coming from the oral infection model 
(data not shown). Nonetheless, overall infected groups had relatively less number of 
live fetuses, more resorptions and more growth restriction on average (Table 2.2 and 
Figure 2.2). Moreover, fecundity was significantly affected in infected groups (Figure 
2.3). Only 16.7% of mice infected with C. rectus and P. gingivalis were able to get 
pregnant and had smaller litter sizes, situation that was not totally unanticipated as 
our previous observations on P. gingivalis infected animals suggested an impairment 
of fecundity [(Collins et al. 1994) and unpublished observations]. Therefore, we 
hypothesize that the difference in fetal restriction outcomes may be related to the 
mucosal immune system clearance at the portal of entry and the consequent low 
bacterial exposure at the placental level. 
Even so, we found a placental inflammatory phenotype along with an 
enhanced TLR4 expression in murine placentas which is suggestive of an active 
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inflammatory response to bacterial exposure. Histologically, placentas from the 
infected groups showed apparent chronic inflammation (Figure 2.4A), and the 
double-staining immunofluorescence analysis showed that TLR4 expression was 
notably confined to trophoblasts in the labyrinth layer (Figures 2.4B-F). Furthermore, 
placental TLR4 mRNA levels showed to be significantly increased almost two-fold in 
the C. rectus-infected group and mildly increased (30%) in the double infection group 
approaching statistical significance (Figure 5, P=0.06). This finding might be 
explained by the limited number of placentas (n=12) available for analysis since only 
17% (2 out of 12) mice were pregnant in the combined infection group. 
TLRs are highly involved in responding to inflammatory processes in the 
presence or absence of infection in several tissues. In particular, TLRs are thought to 
be critical players of the innate immune response during pregnancy, which have 
significant implications for the success or failure in both early and late gestation 
(Gonzalez et al. 2007). Toll-like receptors expression has been described in the 
human placenta, mostly at the dominant cell type: the trophoblast (Abrahams & Mor 
2005, Holmlund et al. 2002, Kumazaki et al. 2004). Trophoblasts are the first cells to 
differentiate from the outer layer of the blastocyst and are believed to participate 
during endometrial implantation and placental development (Cohen & Bischof 2007). 
Trophoblasts have also been proposed to coordinate the immune response during both 
processes by regulating regulate immune cells migration (macrophages and NK cells) 
to the endometrial implantation site through TLRs activation and chemokines 
production (Abrahams et al. 2005, Mor 2008, Mor et al. 2005). Furthermore, 
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abnormalities in decidual TLRs expression or function have been linked to abnormal 
placentation, inflammation, and adverse pregnancy outcomes (Krikun et al. 2007). 
Interestingly, our data suggest that murine placentas develop pro-inflammatory 
features after oral infection with periodontal pathogens, where placental trophoblasts 
notably express more TLR4 as compared to placentas from non-infected mice 
(Figures 2.4C-H), and these observations were also consistent with the placental 
mRNA levels (Figure 2.5). In fact, TLR4 receptors have been shown to mediate the 
murine placental inflammatory response and fetal death to F. nucleatum , and mice 
deficient for TLR-4 show protection against bacterial and LPS-induced preterm birth 
(Liu et al. 2007). Moreover, the selective antagonism of TLR-4 inhibits inflammation 
and preterm uterine contractility in a nonhuman LPS infection model in Rhesus 
monkeys (ms Waldorf et al. 2008). 
The scope of this report was limited to determine TLR4 expression in 
response to oral Gram negative bacteria as proof of principle; however it is possible 
that other type of TLRs participate during the placental immune responses. For 
example, C. rectus offers a wide array of virulence factors including surface layer (S-
layer) proteins (Thompson 2002), cytolethal distending toxin (CDT) (Braun et al. 
1999), GroEL-like proteins (Hinode et al. 1998) and lipopolysaccharide (LPS)(Ogura 
et al. 1996). In addition, P. gingivalis also possess a plethora of virulence factors 
including capsule, fimbriae, proteases (Gingipains) and LPS (O'Brien-Simpson et al. 
2004). Therefore, either C. rectus or P. gingivalis might be able to induce placental 
inflammation via different virulence factors that could potentially be sensed by 
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different TLRs including TLR-2 (peptidoglycans or fimbriae), TLR4 (LPS) or TLR-5 
(flagellin). 
In conclusion, previous models used to mimic chronic infections in mice 
result in dissemination of live oral bacteria to the placental tissues and impair fetal 
growth. However, this mixed oral infection model combines two commensal and 
critical pathogens that in combination are strongly associated with periodontal disease 
in humans (Offenbacher et al. 2007). Therefore, it is plausible to speculate that 
chronic systemic exposure to oral bacteria and related virulence factors may affect 
early pregnancy via pro-inflammatory mechanisms and such hypotheses warrant 
further investigations (Boggess et al. 2003). Further research is also needed to 
characterize the placental TLR response to oral pathogens in humans to elucidate and 
validate pathogenic mechanisms.
  
 
 
3. Chapter 3. Characterization of the invasive and inflammatory traits of oral 
Campylobacter rectus in a murine model of fetoplacental growth restriction 
and in trophoblastic cultures. 
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Abstract 
Campylobacter species (C. jejuni, C. fetus) are well-established enteric 
abortofacients in humans and ungulates. Campylobacter rectus however is a 
periodontal pathogen that has recently been associated with human fetal exposure and 
adverse pregnancy outcomes including preterm delivery. Experimental evidence in 
pregnant mice has demonstrated that C. rectus can translocate from a distant site of 
infection to the placenta to induce fetal growth restriction and impair placental 
development. However, placental tissues from human, small-for-gestational age 
deliveries have not been reported to harbor C. rectus despite evidence of maternal 
infection and fetal exposure by fetal IgM response. This investigation examined the 
temporal relationship between the placental translocation of C. rectus and the effects 
on murine fetal growth. BALB/c mice were infected at gestational day E7.5 to 
examine placental translocation of C. rectus by immunohistology. C. rectus 
significantly decreased fetoplacental weight at E14.5 and at E16.5 (P<0.05). C rectus 
was detected in 63% of placentas at E14.5, but not at E16.5 (P<0.005). In addition, 
we studied the in vitro invasive potential of C. rectus in trophoblasts relative to C. 
jejuni by confocal immunofluorescence. C. rectus was able to effectively invade 
human trophoblasts (BeWo) in culture but not murine trophoblasts (SM9-1), and 
showed a trend for more invasiveness than that of C. jejuni (P=0.08). C. rectus 
challenge also significantly upregulated both mRNA and protein levels of human IL-
6 and TNF-α in a dose-dependent manner in human trophoblasts (qPCR and ELISA), 
but did not increase cytokine expression in murine cells, suggesting a correlation 
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between invasion and cytokine activation. In conclusion, the trophoblast-invasive trait 
of C. rectus that appears limited to human trophoblasts may play a role in facilitating 
bacterial translocation and placental inflammation during early gestation.  
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Introduction 
Campylobacter rectus is an exclusively oral Gram-negative, anaerobic and 
motile bacterium with a wide array of virulence factors including flagellum, surface 
layer proteins (S-layer), RTX-type toxins, GroELlike proteins and lipopolysaccharide 
(LPS) (Okuda et al. 1997, Wang et al. 2000, LaGier & Threadgill 2008). Together 
with other oral anaerobic bacteria, C. rectus is associated with the initiation and 
progression of periodontal disease (Ihara et al. 2003, Tanner et al. 1998, Socransky et 
al. 1998). C. rectus has been implicated in the association between periodontal 
disease and adverse pregnancy outcomes. For example, fetal exposure to C. rectus 
has been demonstrated to be higher in preterm than in full term neonates (Madianos et 
al. 2001). Moreover, C. rectus count levels are higher in the oral microbiota of 
pregnant women with increased salivary estradiol concentrations (Yokoyama et al. 
2008). Indeed, C. rectus seems to thrive under high concentrations of estradiol and 
progesterone which have been shown to significantly enhance C. rectus in vitro 
growth (Yokoyama et al. 2005). Other Campylobacter spp. including C. fetus and C. 
jejuni have also been reported to be associated with miscarriages, premature labor and 
severe perinatal infection in both humans as well as in animals (Simor et al. 1986, 
Wong et al. 1990, Allos 2001, O'Sullivan et al. 1988b). It is then plausible that C. 
rectus may be an important contributor to adverse pregnancy outcomes due to its 
ability to disseminate systemically during pregnancy. 
Our laboratory has studied the effects of C. rectus systemic infection on the 
fetoplacental unit using a murine model of intra-chamber injection with live bacteria 
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(Yeo et al. 2005). This intra-chamber model demonstrated that remote subcutaneous 
C. rectus maternal infection increases fetal resorptions and induces fetal growth 
restriction (Offenbacher et al. 2005). C. rectus infection also results in abnormal 
placental architecture, as evidenced by the decreased width of the vascular labyrinth 
and the increased width of decidual tissue in the placentas of infected growth-
restricted mice (Bobetsis et al. 2007). If C. rectus disseminates systemically to reach 
the placenta it is then likely to interact with placental cells that express pattern 
recognition receptors (i.e. Toll-like receptors) (Abrahams et al. 2004), and 
subsequently induce a proinflammatory response that ultimately may contribute to an 
adverse pregnancy outcome. Indeed, recent results from our group have suggested 
that murine placentas from oral C. rectus-infected dams show enhanced placental 
TLR-4 expression along with increased vasodilation in the junctional zone 
surrounded by focal areas of inflammatory infiltrate (Arce et al. 2009). 
The in vitro interactions of C. rectus with placental cells are yet to be studied. 
Hypothetically, direct C. rectus contact with trophoblasts may alter gene expression 
and induce a proinflammatory response. C. rectus may also have the ability to invade 
placental trophoblasts since other Campylobacter species have been shown to readily 
invade host or immunocompetent cells, a feature that may play a role in their 
virulence potential. For example, C. jejuni invasion of enterocytes has been shown to 
induce oncotic changes in these cells with extensive cytoplasmic vacuolation and loss 
of plasma membrane integrity, an important feature in the pathogenesis of bacterial 
enteritis (Kalischuk et al. 2007). Moreover, bacterial invasion into mammalian cells 
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has also been proposed as an important mechanism to evade phagocytic immune cells 
and allow systemic dissemination and bacterial translocation to different tissues (Li et 
al. 2008, Medina et al. 2003). 
In this report we evaluated the presence of C. rectus in the placenta of 
pregnant mice that were infected subcutaneously with live bacteria. We also 
evaluated the in vitro ability of C. rectus to invade human as well as murine 
trophoblast cells, and whether C. rectus infection induces changes in two important 
proinflammatory genes at the messenger RNA and protein levels.  
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Materials and Methods 
Mouse Model of C. rectus infection: All procedures were in accordance with 
the animal welfare guidelines and approved by the University of North Carolina-
Chapel Hill Institutional Animal Care and Use Committee. The mouse infection 
model used was similar to that described before (Yeo et al. 2005). BALB/c mice were 
housed under controlled and standardized conditions with 12-hour light-dark cycles. 
Regular mouse diet and water were provided ad libitum. Females were enrolled in the 
experiments at approximately 6 weeks of age and immediately had a steel chamber 
implanted subcutaneously. After one month of healing, females were mated overnight 
with males of the same strain. The next morning, females were removed from the 
male cages and examined for vaginal plugs. If a plug was found, that day was 
recorded as embryonic day E0.5. At E7.5, pregnant mice received an intra-chamber 
injection of 100 μl of 109 CFU/mL live C. rectus or saline. Mice were then sacrificed 
at E14.5 and fetuses (n=15 from 3 non-infected dams and n=25 from 4 infected dams) 
and their respective placental tissues were collected. In preliminary experiments to 
establish the growth restriction model we collected weight data for fetoplacental units 
obtained from 27 non-infected dams and 32 infected dams sacrificed at E16.5. For 
histological analysis, placentas were collected and bisected sagitally then fixed in 4% 
paraformaldehyde and embedded in paraffin. Sections (6 μm) were stained using 
standard hematoxylin and eosin protocols and imaged using a Nikon Microphot-FXA 
Microscope equipped with a QImaging Micropublisher CCD camera. Morphometric 
measurements of the area occupied by each placental layer, namely decidua, 
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spongiotrophoblast layer and labyrinth, were conducted using the “Image J” software 
(http://rsb.info.nih.gov/ij/). For detection of C. rectus in placental tissues, placentas 
from 2 control mice (n=10) and 2 infected mice (n=11) from gestational day E14.5 
were examined by immunostaining. Briefly, sections were de-paraffinized, re-
hydrated in ethanol/H2O washes and permeabilized by incubation in 0.2% Triton X in 
PBS. Slides were then incubated for 1 h in blocking buffer (5% BSA, 1% goat serum 
and 0.2% Triton-X in PBS) and then incubated overnight at 4ºC with a FITC-
conjugated anti-Campylobacter antibody (Kirkegaard & Perry Labs, MD) and Texas 
Red-conjugated Phalloidin (Invitrogen, CA). Slides were washed several times in 
PBS and visualized with a Zeiss LSM5 Pascal Confocal Laser Scanning Microscope 
and 63X na 1.4 plan apo and 100X na 1.3 plan neofluar lenses. Images were captured 
using the LSM510 software. Images obtained from preliminary E16.5 experiments 
were included for comparison purposes. 
Mammalian cell lines: The human trophoblast cell line BeWo (ATCC CCL-
98) derived from a human choriocarcinoma (Pattillo & Gey 1968) and the mouse 
trophoblast cell line SM9-1 (a kind gift from JS Hunt, University of Kansas Medical 
Center, Kansas City, KS) derived from a gestational day 9 Swiss-Webster mouse 
placenta (Bowen & Hunt 1999) were used for invasion experiments and cytokine 
assays. The Madin-Darby canine kidney epithelial cell line MDCK (ATCC CCL-34) 
was used as a positive control for C. jejuni invasion as documented elsewhere (Wine 
et al. 2008). BeWo cells were grown in Ham's F12K medium with 2 mM L-glutamine 
adjusted to contain 10% fetal bovine serum (FBS) according to ATCC propagation 
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instructions. SM9-1 cells were grown in RPMI-1640 supplemented with 1 mM 
sodium pyruvate, 5 10
-5
 M 2-mercaptoethanol and penicillin/streptomycin. Culture 
medium for MDCK cells was Eagle’s Minimum Essential Medium with 10% FBS. 
All cells were grown in T-25 flasks (Corning, Life Sciences, MA) or onto cover slips 
placed at the bottom of a well in 24-well plates for invasion analysis. All cells were 
grown at 37°C in 10% CO2. 
Bacterial cultures: Campylobacter rectus strain 314 or Campylobacter jejuni 
strain ATCC 43457 were used for infection experiments. C. rectus 314 is an oral 
isolate from a periodontal disease patient. C. rectus was grown under anaerobic 
conditions at 37 C on Trypticase soy broth agar (Becton Dickinson and Company, 
Cockeysville, MD) supplemented with 0.2% yeast extract, 0.3% Phytone peptone, 
0.2% NaCl, 0.3% ammonium formate, 0.4% sodium fumarate and 0.4% L-
asparagine, adjusted to pH 7.8. C. jejuni was grown on Mueller Hinton agar (Oxoid, 
Cambridge, UK) plates at 37 C under a microaerophilic atmosphere. 
Invasion assays: Mammalian cells were grown onto cover slips in 24 well 
plates until 80-90% confluency. Bacterial strains were harvested from agar plates 
after 72 h incubation (48 h incubation yielded adequate growth for C. jejuni) and 
resuspended in tissue culture medium without antibiotics to an optical density of 1.00 
(600 nm). Mammalian cell monolayers were also washed 3 times with cell culture 
medium without antibiotics prior to inoculation with bacteria. Bacterial cells were 
added to obtain a multiplicity of infection (MOIs) of 100 bacteria/mammalian cell, 
after which plates were centrifuged at 250  g for 5 min, incubated for 5h at 37°C in 
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10% CO2 and washed with PBS. This time point and MOI were chosen for 
quantification as pilot experiments showed that a similar number of C. rectus cells 
were found intracellularly at 5h, 12h and 24h (data not shown). For visualization of 
adhesion/invasion, infected and non-infected controls were then washed 3 times with 
PBS to remove non-adhered bacteria and fixed with 4% paraformaldehyde for 30 min 
at room temperature. After washing twice with PBS, cells were permeabilized with 
0.2% Triton X-100 in PBS for 15 min. Blocking buffer (5% BSA, 1% goat serum and 
0.2% Triton-X-100) was added for 1 h and cells were incubated overnight at 4°C with 
a FITC-conjugated anti-Campylobacter antibody and Texas Red-conjugated 
Phalloidin. Cells were then washed several times with PBS. Cover slips were 
mounted on glass slides and observed using a Zeiss LSM5 Pascal Confocal Laser 
Scanning Microscope and 63X na 1.4 planapo and 100X na 1.3 plan neofluar lenses. 
Random fields were captured using the LSM510 software. Quantification of bacterial 
adhesion and invasion was done manually using the LSM510 software and the ortho 
view to navigate the entire stack of images visualizing x, y and z planes. Image stacks 
of up to 8 random fields were used for quantification of invasion/adhesion by 
confocal microscopy. 
Proinflammatory gene expression and cytokine assays: Infected cells at 
MOI 50, 100 and 500 during 12 hours and non-infected controls were washed 3 times 
with PBS to remove non-adhered cells. The MOIs were determined by performing 
preliminary experiments testing over a range of MOI that extended from 5 to 1000 
MOI. Additional experiments were also performed to include ultrapure E. coli LPS 
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(0111:B4 strain, Invivogen, San Diego, CA) using 1ug/well as positive control for 
proinflammatory gene expression. Total RNA was isolated from cells with the use of 
the miRNeasy Mini Kit (Qiagen, CA). 1 µg of total RNA was reversely transcribed 
using the Omniscript system (Qiagen, CA). Real-time PCR was performed with 1 µL 
of the cDNA reaction in a 7500 Sequence Detection System (ABI Prism, Applied 
Biosystems, CA). TaqMan pre-inventoried assays for human (Hs00985639_m1) and 
mouse (Mm00446190_m1) Interleukin 6 (IL-6) as well as for human 
(Hs99999043_m1) and mouse (Mm99999068_m1) tumor necrosis factor alpha (TNF-
α) were used for relative gene expression quantification. Reactions were performed in 
duplicates and two independent assays were carried out for each gene. The 18S 
ribosomal RNA subunit gene and the Glyceraldehyde-3-Phosphate Dehydrogenase 
(gapdh) gene were used as endogenous housekeeping controls for human (BeWo) and 
murine (SM9-1) trophoblast cells respectively. Results were evaluated using the 
delta-delta Ct method, where delta Ct was calculated as (gene of interest Ct) − 
(housekeeping gene Ct), and the relative quantity of mRNA expression was 
calculated by the delta–delta Ct as 2−[(infected sample delta Ct)−(non-infected sample delta Ct)]. The 
quantification of IL-6 and TNF-α in cell supernatants was performed by means of 
xMAP multiplexing cytokine assays. Briefly, cell supernatants were collected after 
timed infection, centrifuged at 1.500 x g for 5 minutes and then frozen until analysis. 
Multianalyte kits for human and mouse IL-6 and TNF-α were used following the 
manufacturer instructions (Fluorokine MAP Kits, R&D systems, MN). 
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Statistical analysis: A minimal sample size of 8 mice per group was 
calculated [power (1 − β) of >0.90% with alpha-error threshold of (α) = 0.05] based 
on our previous results on fetal growth restriction after C. rectus systemic infection at 
E16.5 (Yeo et al. 2005). Continuous variables were expressed as means and standard 
deviations. Mean placental weight values for control and infected mice were 
compared using the unpaired Student’s t test. The detection frequency of C. rectus in 
infected and non-infected murine placentas was compared by using the Fisher’s exact 
test. Counts of C. rectus invasion/adhesion in cells were compared using the unpaired 
Student’s t test. mRNA fold differences and protein concentration differences were 
compared using one-way ANOVA. The threshold for statistical significance was set 
at a P value less than 0.05. All analyses were performed using SAS v.9.2. (SAS 
Institute, Cary, NC).  
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Results 
C. rectus induces growth restriction and translocates from a distant site of 
infection to the murine placenta in vivo. C. rectus infection impaired the 
development of the fetoplacental unit at day E14.5 and E16.5 (Table 3.1). At E14.5, 
mice infected with C. rectus had a significant lighter placental weight (0.104±0.02 
grams) and fetoplacental weight (0.236±0.04 grams, n=25) compared to the average 
placental weight (0.118±0.02 grams, P=0.03) and fetoplacental weight (0.262±0.03, 
n=15, P=0.02) of non-infected mice. At E16.5, fetoplacental weight showed a similar 
trend to that of E14.5 (0.570±0.004 grams in C. rectus-infected mice vs. 0.612±0.004 
grams in non-infected mice) and this difference was even more significant 
(P>0.0001); however we observed a different trend for placental weight at E16.5, 
where C. rectus-infected placentas were heavier than non-infected controls 
[0.14±0.005 vs. 0.132±0.002 grams respectively, (P>0.0001)], probably because 
infected placentas presented higher cellular inflammatory infiltration leading to 
placental edema (Offenbacher et al, 2005). Also, in contrast to our previous findings 
at E16.5 (Bobetsis et al. 2007), the morphometric analysis of the placentas from 
infected mice showed no significant differences in the mean percentage area of each 
of the placental zones when compared to controls at E14.5 [49±8.45 vs. 53.8±14.0 
respectively, P=0.08); however, a trend for an increase in the size of the decidua layer 
in infected placentas from fetuses with the lowest weight was noted. We also 
observed focal areas of inflammatory infiltrate in the junctional zone of infected 
placentas as reported previously for E16.5 (data not shown). 
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Table 3-1 Growth restriction in fetoplacental units at day E14.5 and E16.5 after 
C. rectus infection. 
 
 
 
Data represent mean values ± SD per group. Pregnant mice received an intra-chamber 
injection of live C. rectus or saline at E7.5. Mice were sacrificed at E14.5 and 16.5 
for the analysis of their fetoplacental tissues. Mean placental and fetoplacental weight 
were significantly different between non-infected controls and C. rectus-infected 
mice. n values correspond to the number of fetuses or placentas analyzed.  
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Immunofluorescence labeling of C rectus on murine placental tissues and 
trophoblasts in culture is depicted in Fig. 3.1. C. rectus was detected in 7 out of 11 
stained placentas (63.6%) from infected mice (Fig. 3.1b and 3.1c) and in none of the 
10 placentas from non-infected controls (Figure 3.1a) (P=0.004) at E14.5. The 
presence of bacterial cells was not observed in the majority of the scanned fields in 
infected placental tissues, as the bacteria were rather scarcely distributed and seen as 
single or coupled bacteria cells. No bacterial cells were observed in murine placentas 
analyzed at E16.5 (data not shown). 
C. rectus adheres and invades human trophoblasts. C. rectus adhesion and 
invasion, as visualized by confocal microscopy, was evaluated in murine and human 
trophoblasts. In addition, we compared the invasiveness of the oral C. rectus to a 
highly invasive intestinal pathogenic strain of C. jejuni. Epithelial cells (MDCK) 
served as positive control for Campylobacter invasion.  Fig.3.1e shows extracellular 
and intercellular localization of C. rectus without cytoplasmic invasion in murine 
trophoblasts. At the same microbial load, there was much greater accumulation of C. 
jejuni extracellularly (Fig. 3.1f) without appreciable evidence of intracellular invasion 
for either C. jejuni or C. rectus. However, both bacteria were able to penetrate cell 
junctions and C. jejuni was more efficient than C. rectus at doing so (Table 3.2). In 
contrast, both C. rectus and C. jejuni were able to invade and localize intracellularly 
in the human trophoblast BeWo cells, as well as in the positive control MDCK cells 
(Figure 3.1g-l). In all cases, C. jejuni adhered, penetrated through cell junctions and 
invaded with significantly more efficiency than C. rectus, except for intracellular 
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Figure 3.1 C. rectus invasiveness in murine placentas and mammalian 
trophoblasts. 
 
Immunofluorescence analysis of murine placentas: (a–c) representative images in murine 
placentas from non-infected (a) and infected mice (b and c). C. rectus was seen in placentas 
of infected mice (64%) but not in the placentas of control mice. The presence of bacterial 
cells was rather scarce and was not observed in the majority of the scanned fields: (d–i) 
representative images from in vitro trophoblastic cell infection experiments and non-infected 
controls. Bacteria were found extracellularly attached to murine trophoblasts, or present in 
the cell junctions within cells (e) without apparent evidence of cytoplasmic invasion (f). 
Conversely, C. rectus and C. jejuni were detected intracellularly in the human trophoblast 
BeWo cells (h and i). (j–l) The canine epithelial MDCK cells served as positive control target 
cells using a highly invasive intestinal pathogenic strain of C. jejuni. For all image stacks, red 
stain corresponds to F-actin stained with Texas Red-conjugated Phalloidin. Green-yellow 
fluorescent cells represent bacteria stained with an FITC-conjugated Campylobacter-specific 
antibody. Magnifications: [a–c] at 63× na 1.4 plan apo and [d–l] at 100× na 1.3 plan neo fluar 
lenses.  
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Table 3-2 Quantification of adhesion and intercellular/intracellular localization 
of C. rectus and C. jejuni in trophoblast cells in vitro. 
 
 
 
 
Data represent the mean number of bacterial cells counted in the entire stack of 
images in up to 8 random fields per sample (Fig. 3.1). C. jejuni and C. rectus adhered 
to SM9-1 murine trophoblast cells but invasion was negligible. In contrast, both C. 
jejuni and C. rectus invaded the human trophoblast cell line BeWo and the canine 
epithelial cell MDCK (P < 0.05). It was noted that in most cases C. jejuni 
adhesion/invasion of cells was significantly greater than that of C. rectus. However, 
C. rectus showed a non-significant trend of higher invasiveness counts in BeWo cells 
when compared to C. jejuni (P = 0.08). *P < 0.05 and **P < 0.01.  
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 invasion of the human trophoblast cell line (BeWo) in which C. rectus 
showed a non statistically significant trend for greater invasion over C. jejuni 
(P=0.08). 
C. rectus upregulates IL-6 and TNFα gene expression in human 
trophoblasts. Table 3.3 illustrates the mRNA relative gene fold differences of C. 
rectus-infected cells vs. non-infected controls. Human BeWo cell responses to the 
positive control (E. coli LPS) were upregulated for TNF-α (67.63±0.65) and IL-6 
(11.47±0.28); however gene expression responses to LPS were particularly low for 
the murine SM9-1 cells for both IL-6 (0.74±0.28) and TNF-α (1.12±0.34). A 
statistically significant trend was also observed in C. rectus-infected cells, in which 
dose-dependent responses of proinflammatory genes were observed for IL-6 (P<0.05) 
and TNF-α (P<0.001) in human BeWo cells, but conversely relative gene differences 
in the murine SM9-1 cells were low for IL-6 and TNF-α (Table 3.3). 
In vitro C. rectus infection upregulates proinflammatory cytokine 
expression in human trophoblasts. Figure 3.2 depicts the cytokine concentration 
differences in cell supernatants from infection experiments at 12 hrs. Both human IL-
6 and TNF-α were increased in a MOI-dependent manner. Protein concentration 
differences were significantly different for human IL-6 (P<0.0001) and TNF-α 
(P<0.0001). Murine proinflammatory cytokines were not detected in cell supernatants 
after infection with C. rectus.  
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Table 3-3 Relative proinflammatory gene expression in trophoblastic cultures 
after C. rectus infection in vitro. 
 
 
 
Data represent mean fold changes ± SD normalized to non-infected controls. 
Cells were infected at MOI 50, 100 and 500 during 12 h and the relative expression of 
human or murine IL-6 and TNFα was quantified by qPCR.  
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Figure 3.2 Proinflammatory cytokine expression in human trophoblasts after in 
vitro C. rectus infection. 
 
 
 
 
Box plots depict mean ± SD cytokine concentration values. Cell supernatants 
were harvested and cytokines were quantified by xMAP multiplexing. Human IL-6 
and TNFα were significantly increased in a MOI-dependent manner. *P < 0.05 and 
**P < 0.0001.  
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Discussion 
The chamber infection murine model used in this report aims to simulate 
bacterial chronic exposure in the murine host mimicking the repeated systemic 
challenge that would be associated with a chronic oral infection.  Here we report 
fetoplacental unit restriction at gestational day E14.5 (Table 3.1) along with evidence 
of C. rectus translocation/invasion to the murine placenta in vivo. The human clinical 
isolate C. rectus 314 was detected in 64% of murine placentas after 7 days post 
infection at E14.5 by immunohistology (Fig. 3.1a-c), but C. rectus was not detected at 
E16.5 using the same technique (data not shown). Interestingly, this finding could 
mean that intact bacteria can be found in the placenta at E14.5 but only bacterial 
DNA is detected at E16.5 by means of nested PCR amplifications (Bobetsis et al. 
2007). Since immunofluorescence not only detects viable bacteria but also dead 
bacterial cells, such differences may be partially explained by C. rectus losing 
viability due to limited growth conditions or due to immune clearance. Interestingly, 
C. rectus detection in placental tissues from human, small-for-gestational age 
deliveries have not been reported yet, despite evidence of a remarkable degree of fetal 
antibody seropositivity (cord blood IgM) to C. rectus (Madianos et al. 2001). 
Host cell invasion is an important feature in the pathogenesis of many 
bacteria, including members of the Campylobacteraceae family. Campylobacter 
invasion into host cells has been studied mainly with the enteric pathogen C. jejuni 
(Fields & Thompson 2008, Krause-Gruszczynska et al. 2007). The invasiveness of C. 
jejuni in cultured epithelial cell lines has been proposed to correlate with colonization 
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efficiency and disease outcome (Bacon et al. 2000, Hanel et al. 2004). However, to 
the best of our knowledge this investigation represents the first study to present 
evidence of in vitro C. rectus invasion in trophoblastic cells and this invasion process 
appears to be specific for human trophoblasts (Fig. 3.1). The invasiveness of C. rectus 
evaluated in this study via confocal microscopy appears to be within the range 
reported for other Campylobacter spp. in terms of quantity (0.01-2 bacteria per cell) 
(Biswas et al. 2004). In these studies the number of internalized bacteria seems to 
increase with greater concentrations reaching a plateau at a MOI of 100-200; 
however, even with the most invasive strains only one to three bacteria are 
internalized per cell (Friis et al. 2005). Even though C. jejuni showed significantly 
greater activity in terms of cellular adhesion and paracellular translocation, this study 
supports the finding that scarce bacterial numbers of C. rectus or C. jejuni get 
internalized in human BeWo trophoblasts using similar MOIs. However, we found 
that C. rectus preferentially invades human trophoblasts in vitro (Table 3.2), which 
may indicate that C. rectus is specifically targeting the human placental trophoblast 
which may contribute to the apparent fetoplacental tropism proposed in humans 
(Madianos et al. 2001). Furthermore, the invasion efficiency of C. rectus appeared to 
be greater than the invasiveness of an established placental pathogen such as C. 
jejuni, at least for the C. jejuni strain tested. Similar routes of infection from mucosal 
surfaces to other tissues have been described for different C. jejuni strains, which 
have been shown to internalize into host cells localizing intracellularly (van Alphen et 
al. 2008) and also to translocate through cell junctions disrupting tight junction 
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protein components (Chen et al. 2006). Either bacterial paracellular (through 
junctions between cells) translocation or transcellular (via the cell cytoplasm) 
internalization could potentially be useful for C. rectus to cross the oral epithelial 
barrier and to migrate to distant sites including the developing fetoplacental unit. The 
ability to invade human trophoblasts and localize in their cytoplasm may also confer 
C. rectus protection from immune surveillance while in the immunologically-
protected placental tissue, as demonstrated in other abortofacients such as Listeria 
monocytogenes (Bakardjiev et al. 2006). 
This study also demonstrated that in response to C. rectus challenge a pro-
inflammatory response is induced in human trophoblastic cells. A clear dose-
dependent (MOI) proinflammatory activity was observed in the human BeWo cell 
line (Table 3.3 and Fig. 3.2) as evidenced by the gene expression and protein 
upregulation of IL-6 and TNF-α, two important members of the cluster of 
proinflammatory cytokines involved in pathogenesis of chorioamnionitis, preterm 
labor, low birth weight and preterm premature rupture of membranes associated with 
intraamniotic infections (Gomez et al. 1997). Furthermore, among different placental 
cell populations, trophoblasts in particular have been proposed to play a key role in 
coordinating placental immune responses during implantation and pregnancy 
maintenance (Mor 2008). Trophoblasts are also thought to be primary sentinel cells 
that are involved in microbial clearance preventing microbial translocation of 
infectious agents from mother to fetus (Levy 2007b). 
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The results obtained with human trophoblasts contrast to those obtained with 
murine trophoblasts, which were unresponsive to the C. rectus in vitro challenge and 
did not show significant proinflammatory activity (Table 3.3). Even though the SM9-
1 cell line has been reported to express TNF-α mRNA (Sharma 1998), these murine 
trophoblasts derived from Swiss mice did not offer a significant proinflammatory 
response when challenged by C. rectus. This finding is also supported by the 
observation that SM9-1 murine trophoblasts were not responsive to E. coli LPS-
challenge (1ug/mL) although cells remained viable based upon proliferation assays 
(data not shown). Moreover, C. rectus did not appear invasive in the mouse 
trophoblast cultures, but did co-localize at regions of intercellular junctions 
suggesting that this human pathogen may use a paracellular pathway to effect 
translocation to promote murine growth restriction. In fact, we have observed the 
bacteria confined to blood vessels in the labyrinth rather than in the placental tissues, 
suggesting a different invasion mechanism in vivo. Similarly, it is known that 
differences exist in the response of human and murine epithelial cells to other 
Campylobacter species, as evidenced by differences in the expression of genes 
involved in growth, transcription and steroid biosynthesis in human colonic epithelia 
vs. unresponsive murine colonic cells (Rinella et al. 2006). Others have also reported 
that C. jejuni, which normally does not bind to Chinese hamster ovary cells, binds 
avidly when these cells are transfected with the human alpha1,2-fucosyltransferase 
gene, thus further demonstrating the specificity of Campylobacter spp. for human 
cells (Ruiz-Palacios et al. 2003). To summarize, the differences between human and 
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murine responses suggest that C. rectus may have a recognition system that is specific 
for human trophoblasts which could potentially enhance tropism and immune 
activation in the human host. 
In conclusion, our studies demonstrated that C. rectus has the ability to 
translocate in vivo from a distant site of infection to the fetoplacental unit. The ability 
of C. rectus to invade human trophoblast cell lines and localize intracellularly as well 
as its ability to increase the expression of important proinflammatory cytokines 
highlights its potential to be an important contributor to adverse pregnancy outcomes 
associated with periodontal disease in humans.
  
 
 
4. Chapter 4. TLR4 mediate intrauterine growth restriction after systemic C. 
rectus infection. 
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Abstract 
Campylobacter rectus is a periodontopathogen associated with fetal exposure 
and increased risk for low-birth weight and prematurity in humans. In pregnant mice, 
C. rectus invades placental tissues and subsequentially induces both local placental 
inflammation and fetal intrauterine growth restriction (IUGR). Placental type-4 Toll-
like (TLR4) receptors expression has been reported to be upregulated after C. rectus 
infection, but it is still unclear whether TLR4 mediates placental inflammatory 
responses and IUGR onset in vivo. The objective of this investigation was twofold: to 
examine the effect of in vitro TLR4 neutralization in trophoblastic pro-inflammatory 
activity and to study the IUGR phenotype in a congenic TLR4-mutant mouse strain 
after systemic C. rectus infection in vivo. BeWo trophoblastic cells were infected with 
C. rectus and the subsequent gene expression was assessed by means of a TLR-
specific pathway superarray. Pro-inflammatory cytokine production was assessed by 
means of a multiplexing assay. A subcutaneous chamber model was used in 
BALB/cAnPt (TLR4
Lps-d
) and BALB/cByJ wild-type (WT) females (N=6/group). 
Mice were mated overnight (12H) with corresponding WT or TLR4 deficient males 
once/week and monitored for vaginal plugs/weight changes. Pregnant females were 
then infected (or sham infected) at gestational day (E)7.5 and sacrificed at E16.5 to 
assess IUGR by means of fetal weight/length measurements (grams±SE or 
centimeters±SE). Homozygous (TLR4
lps-d-/-
) and Heterozygous (TLR4
lps-d+/-
) fetal 
phenotypes were selected for analysis. Groups were compared to sham-infected 
BALB/cByJ (WT) mice using the same model (N=27). 143, 37, 47 and 49 fetuses 
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served as unit analysis from sham-infected WT, C. rectus-infected WT, C. rectus-
infected TLR4
lps-d-/-
 and C.rectus-TLR4
lps-d+/-
 groups respectively. We found that the 
TLR4 gene is differentially expressed in C. rectus-infected human trophoblasts over 
other TLRs along with other important pro-inflammatory genes. Neutralizing anti-
human TLR4 antibodies significantly impaired the production of pro-inflammatory 
cytokines in BeWo cells after C. rectus infection in a dose-dependent manner.  Litter 
size/resorptions frequencies among groups showed no statistical differences (P>0.05, 
Chi-square). Maternal C. rectus infection significantly decreased fetal weight 
(0.42±0.057 vs. 0.48±0.068, P<0.05 Anova) and fetal length (1.23±0.094 vs. 
1.44±0.100, P<0.05) in infected WT when compared to sham WT controls. However, 
infected TLR4
lps-d-/-
 mice did not show statistically significant differences in fetal 
weight (0.46±0.073, P>0.05) and length (1.40±0.119, P>0.05) when compared to WT 
controls. Infected WT and infected TLR4
lps-d-/-
 showed to be significantly different in 
their IUGR phenotype (P<0.05, Anova). Furthermore, Heterozygous TLR4
lps-d+/-
 
fetuses showed IUGR phenotype again and were not statistically different from the 
infected WT mice (P>0.05). In conclusion, our data indicates that TLR4 receptors are 
important in mediating pro-inflammatory responses at the trophoblastic cellular level 
and TLR4-deficient fetuses seem to be less susceptible to develop IUGR in response 
to maternal C. rectus infection when compared to sham-infected WT mice, 
suggesting that placental proinflammatory cytokine activation is likely to be mediated 
by TLR4 during low birth weight/preterm delivery pathogenesis.  
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Introduction 
Periodontal diseases (gingivitis and periodontitis) are part of the most 
common infectious diseases affecting up to 50% of Americans (Albandar 2002). As a 
chronic infection in nature, periodontitis exposes the host to microbial challenge for 
extended periods of time leading to a persistent oral inflammatory response that 
ultimately causes alveolar bone resorption and tooth loss. Concomitantly, the 
susceptible host is exposed to repeated bacteremias and systemic inflammatory 
mediators that have been shown to contribute to the pathogenesis of some systemic 
diseases including atherosclerosis and diabetes (Beck & Offenbacher 2005). 
Periodontitis has also been associated to an increased risk for preterm delivery (PTD) 
and preeclampsia in different human populations, suggesting that maternal 
periodontitis and associated bacteria represent an important systemic stressor to both 
the mother and fetus (Ruma et al. 2008). Even though vaginal/uterine microbial 
infections are recognized to be the major contributors to PTD pathogenesis, other 
pathogens have shown coming from different focal infections in the body and 
reaching the developing fetus through hematogenous dissemination. In particular, 
Campylobacter rectus is an exclusively oral Gram negative anaerobe harbored in 
periodontitis-associated oral biofilms that has experimentally shown the competence 
to selectively translocate to the fetoplacental unit and operate as a fetal infectious 
agent eliciting prematurity and growth restriction. Furthermore, our clinical studies 
have found that maternal C. rectus fetal exposure is more frequent in preterm delivery 
cases, as evidenced by low maternal IgG and high fetal IgM antibody responses 
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(Madianos et al. 2001). However, the underlying biological mechanisms leading to 
preterm delivery after oral C. rectus infection still remain to be elucidated. 
PTD is defined by the World Health Organization as birth at less than 37 
completed gestational weeks(1970). PTD is still the major cause of neonatal mortality 
and morbidity in the world and is associated with low birth weight (<2500 grams) and 
long-term adverse sequelae (cerebral palsy, hearing and learning 
problems)(MacDorman et al. 2005). Preterm delivery can be initiated by multiple 
mechanisms including infection, local inflammation, uteroplacental ischemia, 
hemorrhage, stress and other immunologically mediated processes(Romero et al. 
2006).  Even though the precise triggering mechanism has not been established, the 
development of a proinflammatory condition is a common pathway that centralizes 
all multiple risk factors(Romero et al. 1994). Particularly, uterine infections account 
for 25–40% of preterm births and they are strongly linked with the inflammatory 
pathway onset. Uterine infections are known to upregulate the production of local 
pro-inflammatory cytokines, metalloproteinases and prostaglandins that lead to 
membrane weakening, early membrane rupture and uterine contraction 
initiation(Shoji et al. 2007). If inflammation takes place in all multiple PTD-
associated risk factors, then proinflammatory responses are likely to be 
initiated/mediated by the host innate immune system. Toll-like receptors (TLRs) are a 
family of transmembrane proteins that have a primary role in pathogen recognition 
and innate immunity initiation (Brikos & O'Neill 2008). TLRs receptors bind to 
several microbial components or end-products known as pathogen-associated 
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molecular patterns (PAMPs), which include peptidoglycans, lipoteichoic acid, 
flagellin, double-stranded viral RNA, unmethylated bacterial DNA and 
lipopolysaccharide (LPS) among others. After binding and recognition, TLRs are able 
to trigger an array of signaling pathways that ultimately activate downstream 
molecules such as nuclear factor kB (NF-kB) and interferon regulatory factor 3 (IRF-
3) (Uematsu & Akira 2006), which in turn mediate the expression of several 
proinflammatory cytokines as demonstrated in several tissues, including the maternal-
fetal interface (Koga & Mor 2008). TLRs are highly involved in responding to 
inflammatory processes in the presence or absence of infection. In particular, TLRs 
are thought to be a critical component of the innate immune response during 
pregnancy, which have significant implications for the success or failure of 
pregnancies in both early and late gestation (Patni et al. 2007). To date, 13 
mammalian Toll-like receptors homologues have been identified and designated, and 
their expression has been described in the human placenta, mostly at the dominant 
cell type: the trophoblast (Abrahams et al. 2004, Holmlund et al. 2002, Kumazaki et 
al. 2004). Notably, trophoblasts have also been proposed to be involved in 
coordinating the immune response during both embryonic implantation, placental 
development and immunosurveillance (Mor 2008). For example, trophoblast are 
believed to regulate immune cells migration (macrophages and NK cells) to the 
endometrial implantation site by means of TLRs activation and subsequent 
chemokines production (Abrahams et al. 2005); abnormalities in decidual TLRs 
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expression or function have been linked to abnormal placentation, inflammation, and 
adverse pregnancy outcomes (Krikun et al. 2007). 
Our lab has worked on understanding the maternal and fetal biological 
mechanisms leading to preterm delivery in response to C. rectus infection. We have 
hypothesized that C rectus induces a placental innate inflammatory response 
mediated by Toll-like receptors (TLRs). This hypothesis has been elaborated based on 
our observations in pregnant mice experiments using C. rectus as a model of systemic 
infection, in which we have demonstrated: 1) Systemic dissemination ability from 
distant sites of infection (dorsal subcutaneous chamber and oral cavity) to the 
placenta (Arce et al. 2010); 2) Increased local placental inflammatory response 
confined to the decidua along with placental structural alterations (wider junctional 
zone) (Offenbacher et al. 2005); 3) Fetal intrauterine growth restriction induction 
(lighter and smaller pups) (Yeo et al. 2005); 4) Altered gene expression along with 
imprinted genes down-regulation (i.e. Insulin growth-factor 2) via changes in DNA 
methylation patterns (hypermethylation) (Bobetsis et al. 2007, Bobetsis et al. 2010); 
5) trophoblastic TLR-4 increased expression after C. rectus oral infection (Arce et al. 
2009) and 6) in vitro trophoblastic production of TNFα and IL-6 in a dose-dependent 
response to C. rectus infection (Arce et al. 2010). Based on these experimental 
observations, we believe that the local placental inflammatory response may play a 
significant role in mediating IUGR. However, it is still unclear whether TLRs 
mediates placental inflammatory responses and IUGR onset in vivo in response to C. 
rectus exposure. Therefore, this investigation first examined the expression patterns 
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of several genes associated with the TLR pathway including different TLRs by means 
of a gene expression array from C. rectus infected trophoblastic cells in vitro. Then 
we evaluated the effect of using TLR4 neutralizing antibodies in the trophoblastic 
inflammatory response measured by the production of pro-inflammatory cytokines. 
Finally, we evaluated the in vivo IUGR phenotype in a congenic TLR4-mutant mouse 
strain on a Balb/C background after systemic C. rectus infection.  
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Materials and Methods 
Mammalian cell lines: The human trophoblast cell line BeWo (ATCC CCL-
98) derived from a human choriocarcinoma (Pattillo & Gey 1968) was used for gene 
expression analysis and cytokine assays. Briefly, BeWo cells were grown in Ham's 
F12K medium with 2 mM L-glutamine adjusted to contain 10% fetal bovine serum 
(FBS) according to ATCC propagation instructions. Cells were grown in T-25 flasks 
(Corning, Life Sciences, MA) or onto cover slips placed in 6-well plates for the 
experiments. All cells were grown at 37°C in 10% CO2. 
Bacterial cultures: C. rectus 314 aliquots were maintained in Wilkins 
Chalgren anaerobic broth medium (WC broth; DSMZ, Braunschweig, Germany) 
containing 10% skim milk at -80°C. C. rectus aliquots were reconstituted on PRAS 
ETSA plates (Enriched Tryptic Soy Agar from Anaerobe Systems, Morgan Hill CA). 
Bacteria were anaerobically grown under 5% CO2, 10% H2-85% N2 atmosphere at 
37°C for 4-6 days. Bacterial suspensions were prepared from primary cultures at their 
log phase of growth and resuspended in tissue culture medium without antibiotics (in 
vitro experiments) or PBS (in vivo experiments) to an optical density of 1.00 (600 
nm) determined by spectrophotometry (Cecil Instruments, Cambridge, UK) 
corresponding to 1x10
9
 bacteria/ml. 
In vitro infection assays: BeWo cells were grown onto 6-well plates until 80-
90% confluency. BeWo cell monolayers were also washed 3 times with cell culture 
medium without antibiotics prior to inoculation with bacteria. Bacterial cells were 
added to obtain a multiplicity of infection (MOIs) of 500 bacteria/BeWo cell, after 
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which plates were centrifuged at 250  g for 5 min, incubated for 12h at 37°C in 10% 
CO2 and washed with PBS. This time point and MOI were chosen based on previous 
experiments demonstrating a dose-dependent pro-inflammatory activity (Arce et al. 
2010). All experiments were done in triplicates and in two independent times. 
TLR 4 neutralization: Additional infection experiments were done to 
evaluate the effect of using a TLR4 neutralizing antibody in the previously observed 
pro-inflammatory responses. Briefly, BeWo cells were treated with 1 or 2ug of anti-
human TLR4 antibody (AF1478 goat IgG, R&D systems, Minneapolis MN) for 2 
hours before infection. Then BeWo cell monolayers were washed 3 times with cell 
culture medium without antibiotics and were followed by the infection protocol as 
explained before. The concentration for human TLR4 bioactivity neutralization for 
this antibody was chosen based on the lowest dose recommended by the manufacturer 
(1.5 μg/mL). Additional experiments were also performed to include ultrapure E. coli 
LPS (0111:B4 strain, Invivogen, San Diego, CA) using 1 μg/well as a positive control 
for the production of proinflammatory cytokines. 
Cytokine assays and TLR pathway-specific gene expression experiments: 
The quantification of IL-6 and TNF-α in cell supernatants was performed by means of 
xMAP multiplexing cytokine assays. Briefly, cell supernatants were collected after 
timed infection, centrifuged at 1.500 x g for 5 minutes and then frozen until analysis. 
Multianalyte kits for human IL-6 and TNF-α were used following the manufacturer 
instructions (Fluorokine MAP Kits, R&D systems, MN). Infected cells and non-
infected controls were washed 3 times with PBS to remove non-adherent cells. Cells 
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were detached using trizol and total RNA was isolated from cells with the use of the 
miRNeasy Mini Kit (Qiagen, CA). 1 µg of total RNA was reversely transcribed using 
the RT
2
 first strand kit (C-03, Qiagen, CA). Real-time PCR was performed with a 
total of 1ug of the cDNA reaction in a RT² Profiler™ PCR Array Human specific for 
Toll-Like Receptor Signaling Pathway (PAHS-018A, Qiagen, CA ). This platform 
was used to evaluate gene expression changes in infected vs. non infected (control) 
BeWo trophoblastic cells. Reactions were performed using 3 biological replicates per 
group. The Glyceraldehyde-3-Phosphate Dehydrogenase (gapdh) and the Actin-B 
genes were used as endogenous housekeeping controls. Results were evaluated using 
the delta-delta Ct method available at the manufacturer’s web-based PCR array data 
analysis software. All plates were processed in a 7500 Sequence Detection System 
(ABI Prism, Applied Biosystems, CA). 
Congenic TLR4-deficient mouse model of systemic C. rectus infection: All 
procedures were in accordance with the animal welfare guidelines and approved by 
the University of North Carolina-Chapel Hill Institutional Animal Care and Use 
Committee. The mouse infection model used was similar to that described before 
(Yeo et al. 2005). BALB/cAnPt(TLR4
Lps-d
) mice and BALB/cByJ corresponding 
Wild-type (WT) controls were bought from the Jackson Laboratory (C.C3-Tlr4
Lps-d
/J 
stock number 002930 and BALB/cByJ wild type stock number 001026, The Jackson 
Laboratory, Bar Harbor, MA). All mice were housed under controlled and 
standardized conditions with 12-hour light-dark cycles. Regular mouse diet and water 
were provided ad libitum. Females were enrolled in the experiments at approximately 
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6 weeks of age and immediately had a steel chamber implanted subcutaneously as 
previously described (Yeo et al. 2005). After one month of healing, females were 
mated overnight with males of the same or different background (6 females per 
group). The next morning, females were removed from the male cages and examined 
for vaginal plugs. If a plug was found, that day was recorded as embryonic day E0.5. 
At E7.5, pregnant mice received an intra-chamber injection of 100 μl of 109 CFU/mL 
live C. rectus in PBS. Mice were then sacrificed at E16.5 and fetuses (n=47 from 
homozygous TLR4
lps-d-/-
 infected dams and n=49 from heterozygous TLR4
lps-d+/-
 
infected dams) and their respective placental tissues were collected for further 
analyses (fetal length/weight). For comparison purposes, we also included data from 
previous experiments using sham-infected WT controls (n=143) and C. rectus-
infected WT mice (n=37) that were part of the same experimental animal model. 
Statistical analysis: A minimal sample size of 6 mice per group was 
calculated [power (1−β) of >0.90% with alpha-error threshold of (α) = 0.05] based on 
our previous results on fetal growth restriction after C. rectus systemic infection at 
E16.5 (Arce et al. 2010). Continuous variables were expressed as means and standard 
errors. mRNA fold differences between the infected cells (test) and non-infected 
controls were compared using the unpaired T-test. Protein concentration differences 
were compared using the one-way Anova test. Mean placental/fetal weight and fetal 
length values for all groups were compared using the Anova (Kruskal-wallis) test 
with Dunn’s post-hoc comparisons. The frequency of resorptions and litter sizes in all 
groups were compared by using the Chi-square test. The threshold for statistical 
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significance was set at a P-value less than 0.05. All analyses were performed using 
GraphPad software (San Diego California USA).  
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Results 
TLR4 gene is differentially expressed in C. rectus-infected human trophoblasts 
over other TLRs. We first evaluated the expression differences of 80 selected 
mRNA genes in a TLR pathway-specific array platform after in vitro C. rectus (test) 
or sham (control) in vitro infections in trophoblastic BeWo cells. Table 4.1 depicts 
the gene table results for fold differences, fold up/down regulation and T-test P 
values. Overall, most genes (72 genes, 90%) showed a trend towards down-regulation 
when comparing test/control experiments. Among these, only 8 genes (11%) were 
statistically significant (P<0.05). In terms of up-regulated genes (8 genes, 10%), only 
2 genes (25%) were statistically significant (Caspase 8 and Tumor necrosis factor 
receptor 1A). Among up-regulated genes, important members of the TLR pathway 
such as Caspase 8, Colony stimulating factor 2, Interleukin 2, Interleukin 6 and 
Tumor necrosis factor exemplified pro-inflammatory cytokines in relative increased 
transcriptional activity. Interestingly, among 10 TLRs evaluated in the pathway, the 
mRNA expression of TLR type 4 (TLR4) was found to be increased by 1.18 fold in 
C. rectus-cells (1.18 fold upregulation), however this trend showed not to be 
statistically significant (P=0.283, T-test). All other TLRs receptors showed a non-
significant down-regulation trend (Table 4.1). 
Neutralizing anti-human TLR 4 antibodies impaired the production of pro-
inflammatory cytokines in BeWo cells after C. rectus infection in a dose-
dependent manner. We tested the effect on TLR4 neutralizing antibodies pre-
treatment in our in vitro system and then evaluated the production of the pro-  
 103 
 
Table 4-1 Human Toll-Like Receptor Signaling Pathway in C. rectus-infected 
trophoblastic BeWo cells. Upregulated genes are highlighted in red. 
  
Fold Difference T-TEST
Fold Up- or Down-
Regulation
Test Sample 
/Control Sample
p value
Test Sample 
/Control Sample
BTK  Bruton agammaglobulinemia tyrosine kinase  0.41 0.177 -2.44
CASP8 Caspase 8, apoptosis-related cysteine peptidase 1.95 0.022 1.95
CCL2 Chemokine (C-C motif) ligand 2 0.24 0.195 -4.25
CD14 CD14 molecule 0.27 0.168 -3.68
CD80 CD80 molecule 0.56 0.254 -1.78
CD86 CD86 molecule 0.32 0.167 -3.14
CHUK Conserved helix-loop-helix ubiquitous kinase 0.68 0.274 -1.48
CLEC4E C-type lectin domain family 4, member E 0.28 0.164 -3.57
CSF2 Colony stimulating factor 2 (granulocyte-macrophage) 1.06 0.694 1.06
CSF3 Colony stimulating factor 3 (granulocyte) 0.32 0.167 -3.14
CXCL10 Chemokine (C-X-C motif) ligand 10 0.36 0.213 -2.76
EIF2AK2 Eukaryotic translation initiation factor 2-alpha kinase 2 0.40 0.035 -2.49
ELK1 ELK1, member of ETS oncogene family 0.64 0.336 -1.57
FADD Fas (TNFRSF6)-associated via death domain 0.66 0.261 -1.52
FOS V-fos FBJ murine osteosarcoma viral oncogene homolog 0.55 0.083 -1.80
HMGB1 High-mobility group box 1 0.71 0.253 -1.40
HRAS V-Ha-ras Harvey rat sarcoma viral oncogene homolog 0.50 0.108 -1.99
HSPA1A Heat shock 70kDa protein 1A 0.34 0.280 -2.93
HSPD1 Heat shock 60kDa protein 1 (chaperonin) 0.57 0.132 -1.76
IFNA1 Interferon, alpha 1 0.38 0.185 -2.62
IFNB1 Interferon, beta 1, fibroblast 0.41 0.177 -2.44
IFNG Interferon, gamma 0.20 0.228 -5.09
IKBKB Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta 0.46 0.066 -2.17
IL10 Interleukin 10 0.38 0.179 -2.61
IL12A Interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) 0.51 0.301 -1.97
IL1A Interleukin 1, alpha 0.34 0.292 -2.91
IL1B Interleukin 1, beta 0.81 0.518 -1.24
IL2 Interleukin 2 3.38 0.100 3.38
IL6 Interleukin 6 (interferon, beta 2) 2.26 0.215 2.26
IL8 Interleukin 8 0.32 0.240 -3.16
IRAK1 Interleukin-1 receptor-associated kinase 1 0.37 0.132 -2.68
IRAK2 Interleukin-1 receptor-associated kinase 2 0.21 0.129 -4.65
IRF1 Interferon regulatory factor 1 0.49 0.167 -2.05
IRF3 Interferon regulatory factor 3 0.70 0.105 -1.42
JUN Jun oncogene 0.39 0.125 -2.60
LTA Lymphotoxin alpha (TNF superfamily, member 1) 0.26 0.176 -3.87
CD180 CD180 molecule 0.26 0.176 -3.87
LY86 Lymphocyte antigen 86 0.52 0.268 -1.91
LY96 Lymphocyte antigen 96 0.29 0.161 -3.46
MAP2K3 Mitogen-activated protein kinase kinase 3 0.85 0.810 -1.18
MAP2K4 Mitogen-activated protein kinase kinase 4 0.82 0.437 -1.22
MAP3K1 Mitogen-activated protein kinase kinase kinase 1 0.43 0.137 -2.31
MAP3K7 Mitogen-activated protein kinase kinase kinase 7 0.80 0.187 -1.25
MAP3K7IP1 Mitogen-activated protein kinase kinase kinase 7 interacting protein 1 0.71 0.321 -1.40
MAP4K4 Mitogen-activated protein kinase kinase kinase kinase 4 0.51 0.026 -1.97
MAPK8 Mitogen-activated protein kinase 8 0.39 0.117 -2.60
MAPK8IP3 Mitogen-activated protein kinase 8 interacting protein 3 0.36 0.047 -2.80
MYD88 Myeloid differentiation primary response gene (88) 0.37 0.016 -2.71
NFKB1 Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 0.66 0.245 -1.51
NFKB2 Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) 0.70 0.279 -1.42
NFKBIA Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha 0.62 0.288 -1.61
NFKBIL1 Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1 0.62 0.244 -1.60
NFRKB Nuclear factor related to kappaB binding protein 0.50 0.054 -1.98
NR2C2 Nuclear receptor subfamily 2, group C, member 2 0.67 0.113 -1.48
PELI1 Pellino homolog 1 (Drosophila) 0.62 0.138 -1.60
PPARA Peroxisome proliferator-activated receptor alpha 0.40 0.066 -2.50
PRKRA Protein kinase, interferon-inducible double stranded RNA dependent activator 0.75 0.157 -1.33
PTGS2 Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) 0.42 0.187 -2.39
REL V-rel reticuloendotheliosis viral oncogene homolog (avian) 0.26 0.125 -3.85
RELA V-rel reticuloendotheliosis viral oncogene homolog A (avian) 0.35 0.007 -2.83
RIPK2 Receptor-interacting serine-threonine kinase 2 0.74 0.346 -1.35
SARM1 Sterile alpha and TIR motif containing 1 0.56 0.133 -1.78
SIGIRR Single immunoglobulin and toll-interleukin 1 receptor (TIR) domain 0.27 0.226 -3.68
ECSIT ECSIT homolog (Drosophila) 0.50 0.054 -2.01
TBK1 TANK-binding kinase 1 1.05 0.956 1.05
TICAM2 Toll-like receptor adaptor molecule 2 0.58 0.102 -1.72
TIRAP Toll-interleukin 1 receptor (TIR) domain containing adaptor protein 0.45 0.024 -2.20
TLR1 Toll-like receptor 1 0.32 0.167 -3.14
TLR10 Toll-like receptor 10 0.42 0.166 -2.36
TLR2 Toll-like receptor 2 0.26 0.175 -3.84
TLR3 Toll-like receptor 3 0.51 0.284 -1.96
TLR4 Toll-like receptor 4 1.18 0.283 1.18
TLR5 Toll-like receptor 5 0.25 0.222 -3.97
TLR6 Toll-like receptor 6 0.54 0.234 -1.85
TLR7 Toll-like receptor 7 0.34 0.178 -2.95
TLR8 Toll-like receptor 8 0.32 0.167 -3.14
TLR9 Toll-like receptor 9 0.26 0.055 -3.84
TNF Tumor necrosis factor (TNF superfamily, member 2) 1.95 0.238 1.95
TNFRSF1A Tumor necrosis factor receptor superfamily, member 1A 122.44 0.000 122.44
TOLLIP Toll interacting protein 0.37 0.075 -2.73
TRAF6 TNF receptor-associated factor 6 0.70 0.190 -1.44
TICAM1 Toll-like receptor adaptor molecule 1 0.52 0.003 -1.94
UBE2N Ubiquitin-conjugating enzyme E2N (UBC13 homolog, yeast) 0.39 0.022 -2.54
UBE2V1 Ubiquitin-conjugating enzyme E2 variant 1 0.94 0.840 -1.07
Symbol Description
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inflammatory cytokines IL-6 and TNFα as outcome measurements by means of 
multiplexing assays. As depicted in Figure 4.1, there was a dose-dependent effect in 
the neutralizing activity of TLR4AB in reducing pro-inflammatory activity in BeWo 
cells. For example, for total IL-6 production in response to MOI500 there was a 
statistically significant decrease to 46.4% when cells were pre-treated with 1ug 
TLR4AB (34.0±9.02 pg/mL), and a further decrease to 17.1% was evident when 
using 2ug of TLR4AB (12.5±4.18, P<0.05, Anova). Similarly, a similar trend was 
also observed for TNFα, in which total production was decreased to 48.1% when 
using 1ug TLR4AB (4.9±1.80) and to 33.6% when using 2ug TLRAB (3.4±0.32, 
P<0.05, Anova). We also evaluated the pro-inflammatory responses to a classical 
TLR4 agonist (E. coli LPS) as a positive control for the experiment, finding a 
significant decrease for both IL-6 (21.5%) and TNFα (31%). 
TLR4-deficient fetuses are less susceptible to IUGR after maternal C. rectus 
systemic infection. We sought to evaluate the in vivo effect of a deficient TLR4 
receptor congenic murine strain on IUGR after systemic C. rectus exposure. In terms 
of litter sizes an frequency of fetal resorptions there were no statistical differences 
among all experimental groups (P>0.05, Chi-square). Differences in fetal weight are 
shown in Figure 4.2. WT fetuses from sham-infected dams had an average weight of 
0.47±0.005 grams. When infected with C. rectus, WT dams delivered IUGR fetuses 
that had an average weight of 0.42±0.009. However, when TLR4
lps-d
 dams were 
mated with males of the same genetic background and then infected with C. rectus, 
their TLR4
lps-d-/-
 homozygous fetuses appeared not to be affected by the infection as 
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their average weight of 0.46±0.010 did not statistically differ from the WT control 
dams (P>0.05, Kruskal-wallis).  
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Figure 4.1 TLR4 neutralization in trophoblastic cells affects cytokine production 
after in vitro C. rectus infection. 
 
BeWo cells were pre-treated with 1ug or 2ug of a TLR4AB showing a dose-response decrease in IL-6 
and TNFα production. Cr=C. rectus. * P<0.05  
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Furthermore, when TLR4
lps-d
 dams were mated with a male from a different genetic 
background (WT) and after C. rectus infection, the IUGR phenotype of TLR4
lps-d+/-
 
heterozygous fetuses was more evident as the average fetal weight of 0.43± 0.008 
was statistically different from the WT controls (P<0.05, Kruskal-wallis). A very 
similar trend was also observed for the fetal length (expressed in cms) as illustrated in 
Figure 4.3. For example, WT controls had an average size of 1.440± 0.008 and when 
WT dams were infected by C. rectus fetuses were found to be significantly smaller 
(1.229±0.01, P<0.05, Kruskal-wallis). However, infected homozygous TLR4
lps-d-/-
 
fetuses were larger than infected WT (1.396±0.019) and were not statistically 
different from WT controls (P>0.05). Infected heterozygous TLR4
lps-d+/-
 on the other 
hand showed again smaller fetuses (1.251±0.012) that were significantly different 
from fetuses from the WT controls.  
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Figure 4.2 Fetal weight is not significantly affected in TLR4-deficient fetuses 
from C. rectus-infected dams. 
 
 
Box-plots depicting average ± standard errors. The overall Kruskal-Wallis test was 
highly statistically significant (P<0.0001).  Dunn's post-hoc multiple comparison tests 
found statistically significant differences (P<0.05) for Control  WT vs. C. rectus-
infected WT,  Control  WT vs. C. rectus-infected TLR4Lpsd+/- and  C. rectus-
infected WT vs. C. rectus-infected TLR4Lpsd-/-. There were not significant 
differences (P>0.05) for Control  WT vs. C. rectus-infected TLR4Lpsd-/-, C. rectus-
infected WT vs. C. rectus-infected TLR4Lpsd+/- and   C. rectus-infected TLR4Lpsd-
/- vs. C. rectus-infected TLR4Lpsd+/-.  
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Figure 4.3 Fetal length is unaffected in TLR4-deficient fetuses from C. rectus-
infected dams. 
 
Box-plots depicting average ± standard errors. The overall Kruskal-Wallis test was 
highly statistically significant (P<0.0001).  Dunn's post-hoc multiple comparison tests 
found statistically significant differences (P<0.05) for  Control  WT vs. C. rectus-
infected WT, Control  WT vs. C. rectus-infected TLR4Lpsd+/-, C. rectus-infected 
WT vs. C. rectus-infected TLR4Lpsd-/- and for C. rectus-infected TLR4Lpsd-/- vs. 
C. rectus-infected TLR4Lpsd+/-. There were no significant differences for Control  
WT vs. C. rectus-infected TLR4Lpsd-/- and C. rectus-infected WT vs. C. rectus-
infected TLR4Lpsd+/-.  
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Discussion 
Preterm delivery affects 12.5% of live pregnancies the United States (Abrahams 
2008) and is still the major cause of neonatal morbidity and mortality. Even though 
the etiology of pregnancy complications remains somewhat elusive, there is a strong 
association between infections and PTD (Goldenberg et al. 2000). Moreover, the 
available clinical evidence to date suggests that the way such infections could lead to 
prematurity involves the host immune response toward the infectious agent, leading 
to subsequent inflammation (Romero et al. 2007). These clinical observations have 
been confirmed by a number of animal models demonstrating a PTD phenotype in 
response to experimental infection with heat-killed, live bacteria or isolated bacterial 
components that are able to trigger an inflammatory cascade at the fetoplacental level 
(Elovitz 2006). 
For all these reasons, Toll-like receptors (TLRs) have gained a lot of attention in PTD 
research in the last decade. TLRs are a class of proteins that play a key role in the 
innate immune system. They are single, membrane-spanning, non-catalytic receptors 
that recognize structurally conserved molecules derived from microbes(Uematsu & 
Akira 2006). Once microbes breach physical barriers such as the skin, intestinal tract 
mucosa or the fetal maternal interphase, they are recognized by TLRs which then 
activate immune cell responses. In particular, TLR receptors type 4 (TLR4) have been 
found to be particularly important because TLR4 senses the major Gram negative 
component: lipopolysaccharide (LPS). LPS delivered systemically, intrauterine or 
intra-amniotically triggers PTD in vivo (Elovitz & Mrinalini 2004). Furthermore, 
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mice deficient for TLR4 show protection against bacterial and LPS-induced PTD 
(Wang & Hirsch 2003, Elovitz et al. 2003). Experimental TLR4 antagonism 
suppresses pro-inflammatory responses to bacteria including oral microorganisms in 
vivo (Liu et al. 2007, ms Waldorf et al. 2008). At the cellular level, it has been 
hypothesized that Trophoblast cells, upon recognition of microbes through TLRs, 
may coordinate an immune response by recruiting cells of the innate immune system 
to the maternal-fetal interface, a key feature in PTD and Pre-eclampsia pathogenesis 
(Abrahams & Mor 2005). Trophoblasts are thought to be primary sentinel cells that 
are involved in microbial clearance preventing microbial translocation of infectious 
agents from mother to fetus (Levy 2007a). Researchers have reported that 
trophoblastic cells can upregulate the secretion of pro-inflammatory chemokines (IL-
8 and MCP-1) and cytokines (IL1β, IL6 and TNFα) following the ligation of  TLR-4 
by bacterial LPS, exerting trophoblastic cells to differentially modulate the maternal 
immune system both during normal pregnancy and in the presence of an intrauterine 
infection (Mor 2008). 
Such pro-inflammatory phenotype has also been observed in our experiments using 
the oral periodontal pathogen Campylobacter rectus. C. rectus is an orally-exclusive 
Gram negative anaerobe and motile bacterium that plays a pathogenic role in human 
periodontitis (Rams et al. 1993, Yokoyama et al. 2008). C. rectus shows a wide array 
of virulence factors including LPS (Ogura et al. 1995, Ogura et al. 1996, Takiguchi et 
al. 1996). Interestingly, C. rectus is part of the Campylobacteriacae family which has 
been associated with other diseases showing important pro-inflammatory mechanistic 
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similarities such as Campylobacter jejuni in acute gastroenteritis (Allos 2001) and 
Campylobacter fetus in sheep and cattle abortion (Guerrant et al. 1978, Macuch & 
Tanner 2000, Fujihara et al. 2006). In animal models, C. jejuni and C. fetus infections 
result in impaired fetal development and intrauterine growth restriction (O'Sullivan et 
al. 1988a, O'Sullivan et al. 1988b). Noteworthy, our in vivo and in vitro C. rectus 
infection experiments in pregnant mice and placental cells have consistently shown 
maternal inflammatory serum markers upregulation (Yeo et al. 2005), dissemination 
and invasion to trophoblastic cells and placental tissues and consequent placental pro-
inflammatory response that ultimately result in IUGR (Arce et al. 2010). 
Since we have previously reported that the expression of TLR4 at the placental level 
becomes upregulated in response to oral C. rectus exposure (Arce et al. 2009), we 
sought to evaluate the gene expression profile in BeWo trophoblastic cells limited to 
a TLR-pathway specific superarray platform (80 genes) in response to an in vitro C. 
rectus infection when compared to non-infected cells. Interestingly, a major trend 
toward differential down-regulation was observed in the majority of genes (90%) 
(Table 4.1). However, only 8 genes showed a statistically significant down-regulation 
trend (EIF2AK2, MAP4K4, MAPK8IP3, MYD88, RELA, TIRAP, TICAM1 and 
UBE2N, P<0.05, T test). Conversely, the minority of genes (10%) showed a trend 
toward differential upregulation, and only 2 of these genes were statistically 
significant (CASP8 and TNFRSF1A, P<0.05, T test). Among different members of 
TLRs, the only receptor that showed a non significant up-regulation trend was TLR4 
(1.18 fold difference) and all others showed a non-significant down-regulation trend. 
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Overall, the expression of most genes in the superarray was low in both the control 
(non-infected) and test (C. rectus-infected) groups, so the quantification results 
tended to have greater variations. In addition to this, the number of biological 
replicates was limited to 3 per group which ultimately may have limited the reach of 
statistical significance threshold. Nonetheless, if comparing gene expression changes 
in terms of differential expression, these results could be interpreted as consistent 
with our previous findings of trophoblastic pro-inflammatory activity, in which 
mRNA levels for TLR4, Il-6 and TNFα have showed increased transcriptional 
activity (Arce et al. 2010). Similarly, other studies have been conducted to determine 
changes in TLR-4 expressions in trophoblasts at the placental bed of women with and 
without preeclampsia, finding increased TLR-4 protein expression in interstitial 
trophoblasts of patients with PTD (Krikun et al. 2007) or Pre-eclampsia (Kim et al. 
2005). 
We also have previously reported a dose-dependent response for human IL-6 and 
TNFα production both at the messenger (mRNA) and protein levels in human BeWo 
trophoblasts in response to C. rectus in vitro infection (Arce et al. 2010). We here 
aimed to determine whether the antagonism of TLR4 by means of a neutralizing 
TLR4 antibody (TLR4AB) would impair the observed pro-inflammatory phenotype. 
When BeWo cells were pre-treated with 2 different doses (1 or 2 ug) of TLR4AB for 
2 hours before live bacterial exposure, a statistically significant dose-response 
decrease in the production of IL-6 was observed as depicted in Figure 4.1a (P<0.05, 
Anova for both doses when compared to Cr MOI500). A similar trend was observed 
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for TNFα production (Figure 4.1b, P<0.05, Anova for 2ug when compared to Cr 
MOI500). These results strongly suggest TLR4 dependent activity of BeWo cells in 
response to C. rectus infection. TLR4 experimental antagonism has also demonstrated 
significant effects on a PTD phenotype in different animal models. For example, 
TLR4 receptors have been shown to mediate the murine placental inflammatory 
response and fetal death to Fusobacterium nucleatum, another oral periodontal 
bacterial species associated with PTD (Liu et al. 2007). Moreover, the selective 
antagonism of TLR4 inhibits inflammation and preterm uterine contractility in a 
nonhuman intra-amniotic LPS model in Rhesus monkeys (ms Waldorf et al. 2008). 
Lastly, we aimed to evaluate our current murine model of systemic bacterial exposure 
of C. rectus in pregnant mice on a congenic TLR4-mutant mouse strain on a Balb/C 
background. As reported before , a remote subcutaneous maternal C. rectus infection 
increases fetal growth restriction in Balb/C mice (Yeo et al. 2005, Offenbacher et al. 
2005). As shown in Figures 4.2 and 4.3, when WT dams were infected with C. rectus, 
there was a statistically significant weight dropping (12.5%) and size reduction 
(14.7%)(P<0.05, Kruskall-walis). However, in the absence of functional TLR4 in 
homozygous fetuses, no IUGR phenotype was detected as TLR4
Lps-d-/-
 fetuses were 
not statistically different from sham-infected WT controls for both weight and size 
(P>0.05, Dunn’s). Furthermore, when fetuses carried only 1 allele with a functional 
TLR4 in the heterozygous TLR4
Lps-d+/-
 group the IUGR phenotype was rescued as 
these fetuses were significantly different from WT controls (P<0.05, Dunn’s) and 
comparable to C. rectus-infected WT dams (P>0.05, Dunn’s). To our interpretation, 
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the observed phenotype in our experiments completely supported our hypothesis that 
TLR4 receptors are mediating IUGR after systemic C. rectus infection in mice. This 
is also in agreement with (Liu et al. 2007), who reported that the fetal death rate was 
significantly reduced in TLR4-deficient mice on a TLR4 knock/out strain following 
F. nucleatum infection. 
 
In conclusion, our experimental data indicates that TLR4 is differentially upregulated 
in infected Trophoblastic cells over other TLRs, and when TLR4 is neutralized a 
significant reduction in trophoblastic pro-inflammatory activity can be observed in 
vitro. Moreover, in the absence of a functional TLR4 in mice seems to lead to less 
susceptibility to C. rectus infection (IUGR) in vivo. Collectively, these results suggest 
that the placental proinflammatory responses are mediated by TLR4 during low birth 
weight/preterm delivery pathogenesis. We also speculate that TLR4-antagonistic 
therapies may be used to specifically block infection-associated inflammation during 
pregnancy as proposed by others (Abrahams 2008). TLR4 as a therapeutic target may 
provide new future studies that could have promise to bring new anti-inflammatory 
agents for the treatment or prevention of bacterial-induced Preterm Delivery. 
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5. Final thoughts and future directions. 
We believe that the experimental results presented in this dissertation highlight the 
potential role of the oral bacterium Campylobacter rectus in eliciting pro-
inflammatory responses in human placental tissues, supporting the biological 
plausibility of periodontal disease associations to preterm delivery and low birth 
weight pathogenesis. Nevertheless, data must be carefully interpreted and the study 
limitations must be acknowledged as some questions still remain unanswered.  
 
We first evaluated the IUGR phenotype in response to oral infection with periodontal 
pathogens in Balb/C mice. When two of these pathogens (C. rectus and P. gingivalis) 
were applied during the oral infection period, we actually observed a significant 
impairment in murine fecundity; however we did not examine the biological 
mehanisims leading to this phenotype. While there is no known human evidence 
linking impaired fecundity to periodontal diseases in humans, it is interesting to 
speculate that the deletirous effects of oral bacteria could take place in very early 
phases of pregnancy, specially during trophoblast-mediated blastocyst implantation 
processes. This would explain in part why recent clinical trials evaluating the effects 
of periodontal treatment have failed to prove a significant reduction in preterm 
delivery cases, as periodontal treatment during the second-third trimester may be late 
in protecting a susceptible mother. This mechanism warrants further investigation. 
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When we evaluated the in vitro invasion mechanisms of C. rectus on trophoblastic 
cells, we were surprised to see the unresponsiveness of murine trophoblasts in the 
model. While we used cells of a different genetic background (SM9-1 from Swiss-
Webster) than cells on a Balb/C background, the fact that murine trophoblasts did not 
respond to C. rectus exposure really limits our interpretations in the murine IUGR 
phenotype, as bacteria may be using different pathogenic mechanisms that we do not 
know about. Future research should evaluate trophoblastic cell explants from Balb/C 
placentas to validate or disprove these theories. 
 
Finally, the fact that we found Toll-like receptor type 4 to be important in mediating 
the IUGR phenotype in mice, this model also raises many questions related to C. 
rectus recognition, invasion and clearance mechanisms during IUGR onset. For 
example, we only evaluated TLR4 as a proof-of-principle model but our results may 
be biased and they may miss other important TLRs role in the recognition process. 
Likewise, we could not explain if TLR4 was important in mediating trophoblastic cell 
invasion that would explain the observed pro-inflammatory phenotype. After pro-
inflammatory cytokine upregulation, we still ignore the local and systemic effects of 
cytokinemia in the pathogenesis of IUGR. 
 
Nonetheless, the experimental results here presented also demonstrated the 
importance of TLRs in mediating proinflammatory phenotype both in vitro and in 
vivo infection models in response to C. rectus infection. Taken together, we believe 
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that these results elucidate in part the maternal/fetal biological mechanisms leading to 
PTD in humans when exposed to oral bacteria, bringing new insights, theories and 
health policies in the upcoming future. 
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